Noninfective enteritis and colitis

K11_ENERCOLNONINF

ulcerative colitis: An inflammatory bowel disease involving the mucosal surface of the large intestine and rectum. It may present with an acute or slow onset and follows an intermittent or continuous course. Signs and symptoms include abdominal pain, diarrhea, fever, weight loss, and intestinal hemorrhage.

Suggest a new description

Endpoint definition

↥

Endpoint definition steps	FinnGen
Phenotype data	520210
1. Apply sex-specific rule None	520210
2. Check conditions None	520210
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — K50-K52 Cause of death: ICD-10 — K50-K52 2 out of 7 registries used, show all original rules.	22141
4. Check minimum number of events None	22141
5. Include endpoints K11_CROHN K11_ULCER K11_KELAIBD K11_OTHENTERCOL	24521
6. Filter based on genotype QC (FinnGen only)	24521

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

Level in the ICD hierarchy: 2
First used in FinnGen datafreeze: DF2

NAME	K11_ENERCOLNONINF
CONTROL_EXCLUDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE	K11_CROHN\|K11_ULCER\|K11_KELAIBD\|K11_OTHENTERCOL
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	K5[0-2]
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	K5[0-2]
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Noninfective enteritis and colitis based on the number of shared cases.

Similar with more cases:

Gastrointestinal diseases

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	207160	105742	99878
Only index persons	165360	85830	79530
Unadjusted period prevalence (%)
Whole population	2.90	3.03	2.79
Only index persons	3.10	3.16	3.04
Median age at first event (years)
Whole population	40.44	44.66	35.67
Only index persons	38.30	41.87	34.46

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	24521	13664	10857
Unadjusted period prevalence (%)	4.71	4.66	4.79
Median age at first event (years)	44.08	42.34	46.27

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
22094: Matched controls
220675

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

JF1CG

NOMESCO Finland

Extensive MRI of small bowel

48.7

323.0

741

157

K58.0

ICD-10 Finland

Irritable bowel syndrome with diarrhoea

3.6

323.0

1752

5127

UJF30

NOMESCO Finland

Ileoscopy through colon

11.1

323.0

6220

7492

A09

ICD-10 Finland

Other gastroenteritis and colitis of infectious and unspecified origin

3.1

323.0

5374

20781

208

Kela drug reimbursment

Ulcerative colitis and Crohn's disease

+∞

323.0

10091

K51

ICD-10 Finland

Ulcerative colitis

709.8

323.0

1339

56310

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Ulcerative colitis

+∞

323.0

555

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.9

323.0

2894

10782

O99.6

ICD-10 Finland

Diseases of the digestive system complicating pregnancy, childbirth and the puerperium

33.8

323.0

663

202

GD1AA

NOMESCO Finland

Thorax X-ray examination

1.9

323.0

9130

58733

K51.5

ICD-10 Finland

Left sided colitis

2918.5

323.0

5258

K52.2

ICD-10 Finland

Allergic and dietetic gastroenteritis and colitis

281.5

323.0

838

4AA12

NOMESCO Finland

78.4

323.0

385

UJF12

NOMESCO Finland

Enteroscopy through intestinal stoma

95.0

323.0

374

5562A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctitis

+∞

323.0

338

5561A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis

+∞

323.0

363

A07EA02

ATC

hydrocortisone; rectal

103.9

323.0

3399

386

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

3.3

323.0

8355

34680

H02AB06

ATC

prednisolone; systemic

3.5

323.0

13318

66604

R10.4

ICD-10 Finland

Other and unspecified abdominal pain

2.3

323.0

8968

50650

K51.3

ICD-10 Finland

Ulcerative (chronic) rectosigmoiditis

6175.0

323.0

3247

UJF45

NOMESCO Finland

Flexible sigmoidoscopy with biopsy

5.9

323.0

3483

6774

L01BB02

ATC

mercaptopurine; oral

81.7

323.0

1328

173

A06AC01

ATC

ispaghula (psylla seeds); oral

2.6

323.0

6090

28199

UJF92

NOMESCO Finland

Capsular endoscopy

15.4

323.0

1532

1060

K51.8

ICD-10 Finland

Other ulcerative colitis

2041.5

323.0

2271

K50

ICD-10 Finland

Crohn disease [regional enteritis]

680.5

323.0

468

K50.1

ICD-10 Finland

Crohn disease of large intestine

3101.1

323.0

2054

A07EA01

ATC

prednisolone; rectal

120.9

323.0

669

J01MA02

ATC

ciprofloxacin; systemic

2.4

323.0

9441

52618

K51.0

ICD-10 Finland

Ulcerative (chronic) pancolitis

12664.4

323.0

1210

K52.0

ICD-10 Finland

Gastroenteritis and colitis due to radiation

540.2

323.0

321

K51.9

ICD-10 Finland

Ulcerative colitis, unspecified

1543.1

323.0

5985

K50.9

ICD-10 Finland

Crohn disease, unspecified

2757.8

323.0

2564

H02AB07

ATC

prednisone; oral

3.5

323.0

4512

15147

A07EA06

ATC

budesonide; oral, local oral

123.0

323.0

5389

577

A07EC01

ATC

sulfasalazine; oral, rectal

5.1

323.0

3330

7364

TPH04

NOMESCO Finland

Cathetrisation of vein

2.3

323.0

4898

24704

K50.8

ICD-10 Finland

Other Crohn disease

15188.5

323.0

2697

326

Kela drug reimbursment

Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)

+∞

323.0

1163

5568X

ICD-9 Finland

Idiopathic proctocolitis, Other ulcerative colitis

+∞

323.0

313

K52.88

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

152.8

323.0

3163

241

N02AX02

ATC

tramadol; systemic, rectal

1.8

323.0

8718

58761

C10AC01

ATC

colestyramine; oral

10.3

323.0

1439

1486

K51.1

ICD-10 Finland

Ulcerative (chronic) ileocolitis

+∞

323.0

1574

UJF14

NOMESCO Finland

Enteroscopy of ileoanal anastomosis

165.9

323.0

614

P01AB01

ATC

metronidazole; oral, rectal

2.5

323.0

9905

54876

A12AX

ATC

Calcium, combinations with vitamin D and/or other drugs

2.7

323.0

7958

38338

L04AX01

ATC

azathioprine; systemic

29.5

323.0

4959

2146

D94

ICPC

Chronic enteritis/ulcerative colitis

162.6

323.0

846

K51.2

ICD-10 Finland

Ulcerative (chronic) proctitis

1084.8

323.0

2422

M07.5*K51.9

ICD-10 Finland

Arthropathy in ulcerative colitis

+∞

323.0

384

A02BC02

ATC

pantoprazole; systemic

2.0

323.0

13853

100838

K50.0

ICD-10 Finland

Crohn disease of small intestine

3510.1

323.0

2583

UJF32

NOMESCO Finland

Coloscopy

9.5

323.0

12591

27119

JF1DG

NOMESCO Finland

Small bowel very extensive MRI with with high intensity magnet

66.6

323.0

445

A07EC02

ATC

mesalazine; oral, rectal

216.6

323.0

10381

899

K59.1

ICD-10 Finland

Functional diarrhoea

4.7

323.0

1802

4089

ZX120

NOMESCO Finland

Intravenous

3.5

323.0

2862

8960

L04AB04

ATC

adalimumab; parenteral

9.1

323.0

1038

1188

WX002

NOMESCO Finland

Sedation and analgesia

2.2

323.0

4403

22477

K52.9

ICD-10 Finland

Noninfective gastroenteritis and colitis, unspecified

97.5

323.0

5623

770

4AB02

NOMESCO Finland

46.0

303.1

376

Z04.8

ICD-10 Finland

Examination and observation for other specified reasons

2.4

302.9

2960

13430

K57.3

ICD-10 Finland

Diverticular disease of large intestine without perforation or abscess

2.2

301.9

3523

17412

M07.4*K50.9

ICD-10 Finland

Arthropathy in Crohn's disease [regional enteritis]

+∞

298.4

286

JFH30

NOMESCO Finland

Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy

308.3

297.2

302

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.3

296.9

3205

15260

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

3.8

292.8

1323

3594

K56.6

ICD-10 Finland

Other and unspecified intestinal obstruction

5.0

291.8

995

2055

A07EC03

ATC

olsalazine; oral

328.8

291.5

295

K52.80

ICD-10 Finland

(Hemorrhagic) colitis caused by antibiotics

326.5

289.4

293

JF1BD

NOMESCO Finland

Very extensive small bowel CT

23.6

283.9

414

178

A07DA03

ATC

loperamide; oral

4.4

277.5

1089

2597

A02BC03

ATC

lansoprazole; oral

1.8

263.4

5897

37190

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.6

259.6

2113

8642

A02BC05

ATC

esomeprazole; systemic

1.7

259.6

8065

56136

56909

ICD-8 Finland

Other diseases of intestines and peritoneum, Unspecified

+∞

258.7

248

A04.7

ICD-10 Finland

Enterocolitis due to Clostridium difficile

5.4

253.0

803

1526

Z01.8

ICD-10 Finland

Other specified special examinations

1.9

252.8

4593

26917

A02BC01

ATC

omeprazole; systemic

1.8

239.8

5591

35515

K83.0

ICD-10 Finland

Cholangitis

7.9

238.1

569

737

JN3AD

NOMESCO Finland

Abdominal CT examination

2.7

236.2

1766

6859

L04AX03

ATC

methotrexate; systemic (immunosuppressants)

2.4

234.6

2169

9482

K92.1

ICD-10 Finland

Melaena

3.3

228.2

1265

4027

A05AA02

ATC

ursodeoxycholic acid; oral

6.2

225.7

637

1046

N02BE01

ATC

paracetamol; systemic, rectal

1.7

222.9

17660

154514

D11

ICPC

Diarrhoea

2.2

222.0

2646

13044

R50.9

ICD-10 Finland

Fever, unspecified

2.0

221.0

3136

16643

56300

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Regional enteritis

+∞

214.8

206

202

Kela drug reimbursment

Connective tissue diseases, rheumatoid arthritis and comparable disease

2.2

205.7

2439

11969

K62.5

ICD-10 Finland

Haemorrhage of anus and rectum

3.0

202.2

1250

4288

D50.9

ICD-10 Finland

Iron deficiency anaemia, unspecified

2.6

200.6

1610

6491

JFG00

NOMESCO Finland

Closure of loop enterostomy without resection

17.8

200.5

321

183

NK6QA

NOMESCO Finland

Measurement of bone density from tow or more locations with X-ray

2.7

194.9

1440

5531

L04AC05

ATC

ustekinumab; parenteral

23.1

194.3

285

125

56210

ICD-8 Finland

Diverticula of intestine, Diverticulum (diverticulosis) coli

+∞

190.8

183

J01MA12

ATC

levofloxacin; systemic

1.8

186.0

3587

21167

5589X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis, Other and unspecified non-infectious gastro-enteritis and colitis

+∞

185.6

178

JFA15

NOMESCO Finland

Endoscopic polypectomy in colon

3.1

184.9

1113

3745

56908

ICD-8 Finland

Other diseases of intestines and peritoneum, Alii definiti

+∞

184.5

177

1370

FHL

Colonoscopy, whole colon

16.0

182.7

304

192

WX302

NOMESCO Finland

Thoracal epidural anesthesy

2.9

182.7

1189

4213

WX408

NOMESCO Finland

General anesthesy, balanced

1.6

177.2

5335

35913

J01DB01

ATC

cefalexin; oral

1.6

173.4

16947

149387

56399

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Other

+∞

169.9

163

Z93.2

ICD-10 Finland

Ileostomy status

24.1

166.7

241

101

5560A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis

+∞

165.7

159

N02AA59

ATC

codeine, combinations excl. psycholeptics; systemic

1.5

165.5

8858

68180

C05AA08

ATC

fluocortolone; rectal, topical

1.9

164.0

2800

15777

3042

Kela drug reimbursment

+∞

163.6

157

L04AD01

ATC

ciclosporin; systemic

4.6

163.0

603

1349

R10.3

ICD-10 Finland

Pain localized to other parts of lower abdomen

1.7

162.7

4328

28052

4AA33

NOMESCO Finland

1644.4

162.5

158

N03AX16

ATC

pregabalin; oral

1.7

162.4

4413

28767

A02BA02

ATC

ranitidine; systemic

1.7

161.9

3665

22650

A06AC51

ATC

ispaghula, combinations; systemic

2.8

161.8

1130

4179

JFH10

NOMESCO Finland

Total colectomy and ileostomy

38.1

161.8

208

253

Kela drug reimbursment

+∞

161.5

155

K21.0

ICD-10 Finland

Gastro-oesophageal reflux disease with oesophagitis

2.1

161.5

1999

9932

R10.1

ICD-10 Finland

Pain localized to upper abdomen

1.8

159.8

3188

18922

K62.8

ICD-10 Finland

Other specified diseases of anus and rectum

8.2

158.4

368

456

JF1AD

NOMESCO Finland

Small bowel CT

14.2

157.9

276

197

M07.5

ICD-10 Finland

Arthropathy in ulcerative colitis

762.8

154.4

152

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

153.3

7157

53204

H02AB04

ATC

methylprednisolone; systemic

1.8

149.4

2834

16516

R11

ICD-10 Finland

Nausea and vomiting

2.2

148.8

1718

8268

5552A

ICD-9 Finland

Regional enteritis, Small intestine with large intestine

+∞

146.9

141

A07AA09

ATC

vancomycin; oral

6.0

144.5

416

700

JFB00

NOMESCO Finland

Partial resection of small intestine

5.3

144.3

462

884

E0000UV

ATC

1.5

142.3

7723

59024

A49.9

ICD-10 Finland

Bacterial infection, unspecified

2.0

141.6

1966

10215

JKE98

NOMESCO Finland

Other transduodenal endoscopic operation on bile duct or ampulla of Vater

5.1

140.4

464

921

5584A

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[LÄÄKKEEN AIHEUTTAMA SUOLISAIRAUS]

+∞

138.6

133

56211

ICD-8 Finland

Diverticula of intestine, Diverticulitis coli

+∞

138.6

133

5550A

ICD-9 Finland

Regional enteritis, Small intestine

+∞

137.5

132

601

Kela drug reimbursment

Severe malabsorption of nutrients, mainly fats

6.8

135.7

355

526

JFA98

NOMESCO Finland

Other transluminal endoscopic local operation on intestine

4.5

135.6

511

1164

JFH33

NOMESCO Finland

Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy

336.3

133.7

135

N05CF01

ATC

zopiclone; oral

1.5

132.3

5809

42279

D64.9

ICD-10 Finland

Anaemia, unspecified

2.0

131.5

1809

9349

JFB20

NOMESCO Finland

Ileocaecal resection

12.2

129.8

242

200

K44.9

ICD-10 Finland

Diaphragmatic hernia without obstruction or gangrene

2.2

129.8

1430

6724

N02AE01

ATC

buprenorphine; parenteral, sublingual, transdermal

1.9

129.7

2157

11970

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

2.5

129.6

1098

4531

D12.6

ICD-10 Finland

Benign neoplasm: Colon, unspecified

2.6

129.3

986

3837

H02AB09

ATC

hydrocortisone; systemic

3.5

128.9

630

1810

K56.5

ICD-10 Finland

Intestinal adhesions [bands] with obstruction

4.6

128.9

466

1018

56902

ICD-8 Finland

Other diseases of intestines and peritoneum, Proctitis haemorrhagica (ulcerosa)

+∞

126.1

121

A03CA02

ATC

clidinium and psycholeptics; oral

2.4

125.7

1171

5075

B01AB05

ATC

enoxaparin; parenteral

1.5

124.3

5236

37658

N06AX11

ATC

mirtazapine; oral

1.5

123.0

5883

43463

UJD02

NOMESCO Finland

Gastroscopy

2.6

123.0

992

3982

JGB50

NOMESCO Finland

Mucosal proctectomy and ileoanal anastomosis

+∞

121.9

117

J02AC01

ATC

fluconazole; systemic

1.4

121.8

7327

56662

JFH11

NOMESCO Finland

Laparoscopic colectomy

1183.8

120.9

118

B03BA03

ATC

hydroxocobalamin; parenteral

2.4

119.4

1093

4694

K56.7

ICD-10 Finland

Ileus, unspecified

4.7

118.7

421

902

JAH00

NOMESCO Finland

Laparotomy

3.3

118.4

625

1906

K60.3

ICD-10 Finland

Anal fistula

4.1

118.0

486

1205

UJF02

NOMESCO Finland

Peroral enteroscopy

9.0

117.4

256

286

JH1CG

NOMESCO Finland

Extensive MRI of perianal area

10.7

117.1

233

220

M45

ICD-10 Finland

Ankylosing spondylitis

3.5

114.0

565

1641

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

1.8

112.9

1976

11132

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

3.6

111.6

543

1554

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.5

111.5

4061

28145

5551A

ICD-9 Finland

Regional enteritis, Large intestine

+∞

111.5

107

L27.2

ICD-10 Finland

Dermatitis due to ingested food

5.5

111.4

343

628

M07.4

ICD-10 Finland

Arthropathy in Crohn disease [regional enteritis]

285.2

111.0

113

J01FA10

ATC

azithromycin; systemic

1.4

110.4

11584

98273

L01BA01

ATC

methotrexate; systemic (folic acid analog.)

2.6

109.9

835

3238

K21.9

ICD-10 Finland

Gastro-oesophageal reflux disease without oesophagitis

1.9

108.6

1766

9691

5587A

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[POLYPUS NONNEOPLASTICUS COLI]

+∞

108.3

104

A03FA01

ATC

metoclopramide; systemic, rectal

1.6

107.7

3675

25050

3AC01

NOMESCO Finland

5.5

107.3

331

607

R03AC02

ATC

salbutamol; inhalant

1.4

107.3

10074

83721

JFH20

NOMESCO Finland

Proctocolectomy and ileostomy

106.8

107.0

117

JF1AB

NOMESCO Finland

Passage examination of small bowell with X-ray

4.9

106.3

365

756

JFF10

NOMESCO Finland

Loop enterostomy

8.9

106.3

233

263

K92.2

ICD-10 Finland

Gastrointestinal haemorrhage, unspecified

3.2

106.1

582

1826

D01

ICPC

Abdominal pain/cramps general

1.8

105.9

2131

12554

K52.1

ICD-10 Finland

Toxic gastroenteritis and colitis

272.0

105.9

108

R51.80

ICD-10 Finland

Headache

1.6

105.9

2845

18241

JN1CG

NOMESCO Finland

Extensive MRI examination of upper part of abdomen with high intensity magnet

3.3

105.1

571

1779

J01DA01

ATC

[U] cefalexin; systemic

1.4

104.7

12177

104630

5586X

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[KROONINEN INFLAMMATOORINEN SUOLISTOSAIRAUS, NUD]

+∞

104.2

100

J01AA02

ATC

doxycycline; systemic

1.4

104.0

14901

132447

JFA38

NOMESCO Finland

Endoscopic dilatation of small intestine

264.2

102.8

105

NK4XE

NOMESCO Finland

Joint ultrasound examination not elsewhere classified

2.0

101.4

1314

6602

R06.0

ICD-10 Finland

Dyspnoea

1.5

101.4

4259

30386

R53

ICD-10 Finland

Malaise and fatigue

1.5

101.2

3748

26001

L30.9

ICD-10 Finland

Dermatitis, unspecified

1.6

100.9

3184

21261

JN1DG

NOMESCO Finland

Very extensive MRI examination of upper part of abdomen with high intensity magnet

3.9

98.2

421

1083

JHA00

NOMESCO Finland

Anal or perianal incision

4.3

98.1

382

899

N02AA05

ATC

oxycodone; systemic

1.7

98.1

2373

14751

WX404

NOMESCO Finland

Intravenous generell anesthesy

1.5

98.0

3737

26072

K52.8

ICD-10 Finland

Other specified noninfective gastroenteritis and colitis

+∞

97.9

JFA58

NOMESCO Finland

Endoscopic dilatation of colon

20.8

97.6

147

K43.9

ICD-10 Finland

Other and unspecified ventral hernia without obstruction or gangrene

2.5

97.1

841

3502

UKC02

NOMESCO Finland

Cystoscopy

1.6

96.8

2638

16942

SPAT1263

SPAT

Sampling

1.4

96.8

8082

65478

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

1.4

96.7

7769

62529

D07AC01

ATC

betamethasone; topical

1.4

96.7

6100

47078

K51.4

ICD-10 Finland

Inflammatory polyps

941.6

96.0

UJG02

NOMESCO Finland

Proctoscopy

3.4

95.3

486

1444

M25.5

ICD-10 Finland

Pain in joint

1.4

94.7

5087

38073

WZC00

NOMESCO Finland

Planning of intervention or health care consultation

1.4

93.7

6130

47563

N03AX12

ATC

gabapentin; oral

1.6

93.7

2660

17260

J01FF01

ATC

clindamycin; systemic

1.4

92.9

4871

36264

D50.0

ICD-10 Finland

Iron deficiency anaemia secondary to blood loss (chronic)

2.8

92.7

642

2355

JL5BG

NOMESCO Finland

MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.2

91.0

503

1587

WVA20

NOMESCO Finland

Medicine administration

3.3

90.8

493

1536

N06AA09

ATC

amitriptyline; systemic

1.8

90.6

1715

9882

M79.6

ICD-10 Finland

Pain in limb

1.4

90.5

6289

49244

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

2.9

90.0

567

1955

R07.4

ICD-10 Finland

Chest pain, unspecified

1.4

89.9

4489

33066

5585A

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[ILEITIS TERMINALIS ACUTA]

+∞

89.6

NA3AA

NOMESCO Finland

Lumbar spine X-ray examination without contrast

1.8

89.6

1624

9227

K61.0

ICD-10 Finland

Anal abscess

3.7

89.5

415

1142

WX402

NOMESCO Finland

General anaesthesia

1.6

89.3

2985

20153

L04AA33

ATC

vedolizumab; parenteral

+∞

88.5

J06.9

ICD-10 Finland

Acute upper respiratory infection, unspecified

1.3

88.3

8598

71044

Z01.5

ICD-10 Finland

Diagnostic skin and sensitization tests

1.8

88.1

1781

10478

N06AX21

ATC

duloxetine; oral

1.7

88.1

1936

11684

J01FA06

ATC

roxithromycin; oral

1.4

86.6

7255

58492

N05BA04

ATC

oxazepam; oral

1.4

86.6

4399

32474

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

1.9

86.4

1441

7955

A06AD11

ATC

lactulose; oral

1.6

86.0

2373

15256

UJH02

NOMESCO Finland

Anoscopy

2.3

85.7

805

3494

WZB00

NOMESCO Finland

Telephone receipt or other advice

1.4

85.1

5352

41082

J01EE02

ATC

sulfadiazine and trimethoprim; systemic

1.4

83.7

5257

40327

J45.9

ICD-10 Finland

Asthma, unspecified

1.5

83.3

3098

21401

J20.9

ICD-10 Finland

Acute bronchitis, unspecified

1.5

83.2

3094

21377

Z03.89

ICD-10 Finland

Observation for other suspected diseases and conditions

1.6

83.1

2285

14667

S18

ICPC

Laceration/cut

1.3

83.0

7244

58677

501

Kela drug reimbursment

Cow's milk and / or soy protein allergy in young children

4.7

82.4

294

635

Z03.9

ICD-10 Finland

Observation for suspected disease or condition, unspecified

1.5

82.2

3115

21610

M54.5

ICD-10 Finland

Low back pain

1.4

82.1

5903

46319

M03BX02

ATC

tizanidine; oral

1.3

80.8

11486

99835

K30

ICD-10 Finland

Functional dyspepsia

1.7

80.7

1818

11037

L04AA01

ATC

[U] ciclosporin; systemic

3.7

79.3

368

1014

L04AB06

ATC

golimumab; parenteral

5.2

78.6

253

489

Y83

ICD-10 Finland

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

1.9

78.3

1294

7112

J01.0

ICD-10 Finland

Acute maxillary sinusitis

1.4

78.2

3933

28896

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.0

77.1

1054

5399

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

1.7

76.6

1592

9429

R10.0

ICD-10 Finland

Acute abdomen

2.5

76.4

640

2617

K29.7

ICD-10 Finland

Gastritis, unspecified

2.5

76.4

650

2682

3005

Kela drug reimbursment

Tofacitinib

12.8

76.3

138

108

JX1LA

NOMESCO Finland

Kinetic X-ray of alimentary tract with pictures

19.7

75.9

116

AA1AD

NOMESCO Finland

CT of head and brain

1.4

75.9

3816

28012

R06AE07

ATC

cetirizine; oral

1.3

75.9

8152

67854

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.3

75.8

9740

83143

6419

FHL

Other measure in this category

34.2

75.6

K58.9

ICD-10 Finland

Irritable bowel syndrome without diarrhoea

2.4

75.3

661

2772

D16

ICPC

Rectal bleeding

3.0

74.3

450

1514

I84.2

ICD-10 Finland

Internal hemorrhoids without complication

1.8

74.3

1314

7389

H20.0

ICD-10 Finland

Acute and subacute iridocyclitis

2.3

74.3

742

3317

N39.0

ICD-10 Finland

Urinary tract infection, site not specified

1.6

74.2

2346

15569

A07AA02

ATC

nystatin; oral

1.9

73.8

1080

5677

TNX10

NOMESCO Finland

Arthrocentesis, unspecified region, unspecified region

1.9

73.8

1214

6659

C03CA01

ATC

furosemide; systemic

1.4

72.9

4297

32459

JL5AG

NOMESCO Finland

Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet

5.0

72.0

239

479

B81

ICPC

Anaemia vit B12/folate deficiency

2.4

71.8

641

2710

E86

ICD-10 Finland

Volume depletion

2.9

71.5

452

1565

R01AD08

ATC

fluticasone; nasal

1.4

71.1

5079

39619

A03FA02

ATC

cisapride; oral, rectal

1.8

70.6

1314

7508

XF400

NOMESCO Finland

ECG with 12 standard connections

1.5

70.2

2702

18746

M01AH01

ATC

celecoxib; oral (coxibs)

1.5

70.2

2929

20672

M09.2*K51.9

ICD-10 Finland

Juvenile arthritis in ulcerative colitis

+∞

69.8

R19.8

ICD-10 Finland

Other specified symptoms and signs involving the digestive system and abdomen

3.9

69.5

301

783

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.5

69.3

2289

15336

SPAT1148

SPAT

Treatment of chronic ulcer or burn

1.6

68.9

2143

14150

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

1.7

68.9

1518

9138

E000001

ATC

1.4

68.6

3746

27865

SPAT1256

SPAT

Intramuscular and subcutaneous injection

1.3

68.5

7323

60638

A01AB09

ATC

miconazole; local oral

1.7

68.5

1504

9045

1490

FHL

Sigmoideoscopy (fiberscope)

10.1

68.4

139

138

7890A

ICD-9 Finland

Other symptoms involving abdomen and pelvis, Abdominal pain

2.0

67.4

932

4791

N10

ICD-10 Finland

Acute tubulo-interstitial nephritis

1.6

66.7

2054

13525

5559X

ICD-9 Finland

Regional enteritis, Unspecified site

+∞

66.6

WX110

NOMESCO Finland

Local anesthesy

1.3

66.6

13379

120228

K55.9

ICD-10 Finland

Vascular disorder of intestine, unspecified

10.4

66.6

133

128

R42

ICD-10 Finland

Dizziness and giddiness

1.4

66.6

3471

25581

R01AD09

ATC

mometasone; nasal

1.3

66.6

8185

69016

JFF13

NOMESCO Finland

Terminal enterostomy

13.9

66.4

116

PH2AE

NOMESCO Finland

Ultrasound examination of lower leg veins

1.6

66.4

1767

11211

K29.3

ICD-10 Finland

Chronic superficial gastritis

2.5

66.3

557

2282

K59.9

ICD-10 Finland

Functional intestinal disorder, unspecified

3.5

66.0

323

931

TPH07

NOMESCO Finland

Cathetrisation of artery

1.7

66.0

1626

10100

JFG20

NOMESCO Finland

Closure of enterostomy with resection of exteriorised loop

8.9

65.9

144

163

J01CA04

ATC

amoxicillin; systemic

1.3

65.9

16389

151436

JN3CD

NOMESCO Finland

Abdominal CT examination both without and with contrast

2.4

65.6

609

2627

A09AA02

ATC

multienzymes (lipase, protease etc.)

3.0

65.5

390

1297

DM1AA

NOMESCO Finland

Paranasal sinuses X-ray examination without contrast

2.3

64.9

652

2922

M13.9

ICD-10 Finland

Arthritis, unspecified

1.8

64.9

1213

6938

SPAT1255

SPAT

Intravenous administration of medicine

1.8

64.7

1097

6075

N06AB04

ATC

citalopram; systemic

1.4

64.7

3670

27449

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

1.5

64.5

2369

16243

JL5SB

NOMESCO Finland

Endoscopic retrograd cholangiopancreaticography

3.5

64.5

315

907

A08.4

ICD-10 Finland

Viral intestinal infection, unspecified

2.1

64.4

741

3531

C07AB07

ATC

bisoprolol; oral

1.3

63.4

7473

62536

S01XA20

ATC

artificial tears and other indifferent preparations; ophthalmic

1.3

62.9

6629

54617

UJF34

NOMESCO Finland

Left colonoscopy

5.5

62.8

193

355

N06AX16

ATC

venlafaxine; oral

1.5

62.7

2410

16684

JF1DM

NOMESCO Finland

Very extensive MRI of small bowel (more than 1.5 T)

57.0

62.6

5583A

ICD-9 Finland

Other non-infective gastro-enteritis and colitis[ALLERGINEN SUOLISAIRAUS]

+∞

62.5

K90.0

ICD-10 Finland

Coeliac disease

2.4

62.4

561

2380

DM1QA

NOMESCO Finland

Paranasal sinuses X-ray examination in one projection

2.0

62.2

816

4107

SPAT1262

SPAT

Handing over of treatment supplies

1.4

62.0

2927

21136

TJF80

NOMESCO Finland

Ostomy education

4.4

61.6

232

531

NA3BG

NOMESCO Finland

Lumbar spine MRI examination with high intensity magnet

1.6

61.5

1592

10017

UJK12

NOMESCO Finland

Peroral cholangioscopy

11.6

61.4

116

100

D07AC13

ATC

mometasone; topical

1.3

61.3

4960

39292

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

1.8

60.9

1040

5771

Z98.0

ICD-10 Finland

Intestinal bypass and anastomosis status

7.0

60.8

154

220

NA6BG

NOMESCO Finland

Sacro-iliac joint MRI examination with high intensity magnet

3.1

60.6

344

1109

M03BC51

ATC

orphenadrine, combinations; systemic

1.3

60.2

4799

37907

J01EA01

ATC

trimethoprim; systemic

1.4

60.2

4177

32280

WW200

NOMESCO Finland

Immunization

2.4

60.2

554

2380

56398

ICD-8 Finland

Chronic enteritis and ulcerative colitis, Alia definita

+∞

59.4

D01AC20

ATC

imidazoles/triazoles in combination with corticosteroids; topical

1.4

59.3

3833

29268

M54.9

ICD-10 Finland

Dorsalgia, unspecified

1.6

59.1

1859

12286

K56.0

ICD-10 Finland

Paralytic ileus

4.5

58.5

217

490

N05CF02

ATC

zolpidem; oral

1.4

58.5

2913

21233

J01FA09

ATC

clarithromycin; systemic

1.3

58.4

5588

45310

JFG40

NOMESCO Finland

Revision of enterostomy or colostomy without laparotomy

9.1

58.2

125

138

N05BA01

ATC

diazepam; systemic, rectal

1.5

58.1

2216

15301

D07AB02

ATC

hydrocortisone butyrate; topical

1.3

58.1

4861

38652

F32.9

ICD-10 Finland

Depressive episode, unspecified

1.5

57.8

2189

15085

N05CD07

ATC

temazepam; oral

1.5

57.6

1923

12886

JAH01

NOMESCO Finland

Laparoscopy

2.0

57.3

776

3954

107

Kela drug reimbursment

Pernicious anaemia

2.9

57.3

367

1283

WZC30

NOMESCO Finland

Teaching

1.5

57.3

2111

14462

XQ800

NOMESCO Finland

Prick test

1.7

57.2

1358

8338

L04AA29

ATC

tofacitinib; oral

9.3

57.0

121

131

D18

ICPC

Change in faeces/bowel movements

2.7

56.9

409

1534

R01AD12

ATC

fluticasone furoate; nasal

1.3

56.8

5284

42637

FB1BD

NOMESCO Finland

Extensive CT examination of arteria pulmonalis

1.7

56.3

1198

7125

M01AE03

ATC

ketoprofen; systemic, rectal

1.3

56.3

6308

52208

UJK02

NOMESCO Finland

ERCP

2.6

56.3

428

1660

SPAT1083

SPAT

Initiation and monitoring of IV fluid therapy

2.0

56.2

719

3582

E87.6

ICD-10 Finland

Hypokalaemia

2.4

56.0

508

2166

Z93

ICD-10 Finland

Artificial opening status

9.0

56.0

121

135

M05BA04

ATC

alendronic acid; oral

1.7

55.9

1201

7165

0093A

ICD-9 Finland

Ill-defined intestinal infections, Diarrhoea of presumed infectious origin

3.5

55.8

276

804

D07AD01

ATC

clobetasol; topical

1.5

55.4

2481

17698

JFG73

NOMESCO Finland

Excision of ileal pelvic pouch

281.9

55.2

JN4BD

NOMESCO Finland

Extensive body CT

1.6

54.7

1634

10656

R03BA05

ATC

fluticasone; inhalant

1.4

54.6

3145

23502

K76.9

ICD-10 Finland

Liver disease, unspecified

3.3

54.5

290

893

56907

ICD-8 Finland

Other diseases of intestines and peritoneum, Prolapsus recti

+∞

54.1

G44.2

ICD-10 Finland

Tension-type headache

1.5

54.0

2208

15453

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

2.1

53.5

610

2896

J01MA14

ATC

moxifloxacin; systemic

1.6

53.5

1410

8905

M79.0

ICD-10 Finland

Rheumatism, unspecified

2.2

52.6

583

2734

A04.9

ICD-10 Finland

Bacterial intestinal infection, unspecified

4.6

52.5

187

406

M01AH02

ATC

rofecoxib; oral

1.5

52.5

1991

13714

SAA01

NOMESCO Finland

Simple examination of mouth

1.2

52.0

13575

123815

J01MA06

ATC

norfloxacin; oral

1.5

52.0

2139

14986

K55.0

ICD-10 Finland

Acute vascular disorders of intestine

5.5

51.9

158

288

Z00.4

ICD-10 Finland

General psychiatric examination, not elsewhere classified

1.5

51.9

1710

11405

M01AX17

ATC

nimesulide; oral

1.3

51.8

3766

29228

203

Kela drug reimbursment

Chronic asthma and similar chronic obstructive pulmonary diseases

1.4

51.7

3240

24541

J45.0

ICD-10 Finland

Predominantly allergic asthma

1.6

51.5

1523

9902

J05AB01

ATC

aciclovir; systemic

1.4

51.0

3445

26421

KH1AE

NOMESCO Finland

Urinary tract ultrasound examination

1.8

50.9

895

5009

JF1CM

NOMESCO Finland

Small bowel extensive MRI with with high intensity magnet

34.8

50.9

JFB33

NOMESCO Finland

Other resection comprising small intestine and colon

13.3

50.8

D07BB04

ATC

hydrocortisone butyrate and antiseptics; topical

1.5

50.8

2119

14884

R35

ICD-10 Finland

Polyuria

1.8

50.4

955

5479

D06BX01

ATC

metronidazole; topical

1.5

50.4

1637

10882

D12.8

ICD-10 Finland

Benign neoplasm: Rectum

2.1

50.3

588

2823

D12.5

ICD-10 Finland

Benign neoplasm: Sigmoid colon

2.1

50.1

615

3011

J05AB11

ATC

valaciclovir; oral

1.5

50.1

2097

14733

313

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab, tocilizumab and ustekinumab (rheumatoid diseases)

2.2

50.0

517

2348

JAD30

NOMESCO Finland

Repair of incisional hernia using prosthetic material

2.9

49.7

307

1049

K59.09

ICD-10 Finland

Constipation, unspecified

1.8

49.7

921

5249

M51.1

ICD-10 Finland

Lumbar and other intervertebral disc disorders with radiculopathy

1.4

49.6

2250

16064

D06

ICPC

Abdominal pain localized other

1.6

49.6

1320

8351

R19.4

ICD-10 Finland

Change in bowel habit

2.5

49.5

407

1651

J01DA09

ATC

[U] cefadroxil; inhalant, oral

1.3

49.4

4726

38153

L20.0

ICD-10 Finland

Besnier prurigo

1.6

49.4

1228

7633

X59

ICD-10 Finland

Exposure to unspecified factor

1.4

49.1

3152

23959

Y0599

ICD-8 Finland

Investigation of digestive system

2.9

49.0

313

1093

R4110

NOMESCO Finland

Physiotherapy

1.3

49.0

4329

34553

A02BA04

ATC

nizatidine; systemic

1.6

48.4

1189

7362

K80.2

ICD-10 Finland

Calculus of gallbladder without cholecystitis

1.5

48.3

1716

11642

SPAT1254

SPAT

Administration of medicine

1.4

48.3

2474

18074

J32.0

ICD-10 Finland

Chronic maxillary sinusitis

1.6

48.2

1234

7726

C01DA08

ATC

isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal

1.4

48.2

3203

24473

JHB30

NOMESCO Finland

Rubber band ligature of haemorrhoids or prolapse of mucosa

1.8

48.2

904

5171

JHD30

NOMESCO Finland

Incomplete incision of fistula-in-ano

8.9

48.0

104

117

SPAT1144

SPAT

Treatment of reopened or infected surgical wound

1.7

47.7

1113

6793

UJF30

SPAT

5.6

47.5

143

258

K76.0

ICD-10 Finland

Fatty (change of) liver, not elsewhere classified

2.4

47.5

431

1841

B01AB10

ATC

tinzaparin; parenteral

1.7

47.3

1035

6204

K91.4

ICD-10 Finland

Colostomy and enterostomy malfunction

10.8

47.3

A02BC04

ATC

rabeprazole; oral

1.6

47.3

1338

8600

H04.10

ICD-10 Finland

Dry eye syndrome

1.5

47.3

1515

10036

F32.11

ICD-10 Finland

Moderate depressive episode with somatic syndrome

2.2

47.3

520

2430

JHD20

NOMESCO Finland

Incision of fistula-in-ano

3.7

47.2

216

592

WYA05

NOMESCO Finland

Emergency visit or other similar visit involving procedures

1.2

47.0

8782

76807

JAP00

NOMESCO Finland

Freeing of adhesions in the peritoneal cavity

3.6

47.0

223

630

C07AB02

ATC

metoprolol; systemic

1.4

46.8

3059

23297

281

Kela drug reimbursment

Abatacept, adalimumab, anakinra, certolizumab pegol, etanercept, golimumab, infliximab, ixekizumab, sarilumab, secukinumab and tocilizumab

2.2

46.7

486

2214

J45.1

ICD-10 Finland

Nonallergic asthma

1.6

46.7

1147

7103

R15

ICD-10 Finland

Faecal incontinence

2.4

46.5

410

1725

6403

FHL

Ileocal resection

26.7

46.3

JFB21

NOMESCO Finland

Laparoscopic ileocaecal resection

12.8

46.2

C01DA14

ATC

isosorbide mononitrate; oral

1.4

46.1

2095

14954

L04AA06

ATC

mycophenolic acid; systemic

2.7

46.1

332

1251

D99

ICPC

Disease digestive system other

3.5

46.0

221

630

N17.9

ICD-10 Finland

Acute renal failure, unspecified

2.1

45.8

565

2776

SPAT1249

SPAT

Treatment-related counselling outside office

1.2

45.8

7076

60535

J01MA01

ATC

ofloxacin; systemic

1.6

45.2

1319

8539

XKD00

NOMESCO Finland

Uroflowmetry

1.4

45.2

2210

15994

D07XC01

ATC

betamethasone, combinations; topical

1.5

45.2

1868

13079

K59.0

ICD-10 Finland

Constipation

1.8

45.0

868

5007

1300

FHL

Esophagogastroduodenoscopy (also includes staining)

3.6

44.8

211

593

M09.1*K50.9

ICD-10 Finland

Juvenile arthritis in Crohn's disease [regional enteritis]

+∞

44.8

JGB40

NOMESCO Finland

Excision of rectum and end ileostomy

156.8

44.8

D07AA02

ATC

hydrocortisone; topical

1.4

44.7

2395

17620

SPAT1153

SPAT

Removal of sutures

1.3

44.6

5078

41848

M02AA07

ATC

piroxicam; topical

1.3

44.4

5845

49030

JF2AB

NOMESCO Finland

Colongraphy with X-ray

7.7

44.3

105

137

R03DC03

ATC

montelukast; oral

1.4

44.3

2632

19715

EB1AA

NOMESCO Finland

Tooth X-ray examination

1.2

44.3

9973

88772

C07AA05

ATC

propranolol; systemic

1.3

44.2

3213

24862

SPAT1301

SPAT

No procedures

1.3

44.1

5402

44915

S97

ICPC

Chronic ulcer skin

1.8

44.1

777

4354

C05AA01

ATC

hydrocortisone; rectal, topical

1.8

43.8

817

4662

N06AB03

ATC

fluoxetine; oral

1.4

43.7

2029

14529

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.4

43.7

2498

18584

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

4.3

43.7

166

386

M03BC01

ATC

orphenadrine (citrate); systemic

1.3

43.6

3916

31250

K29.5

ICD-10 Finland

Chronic gastritis, unspecified

2.2

43.6

439

1974

JN4AD

NOMESCO Finland

Body CT examination

1.6

43.5

1088

6769

N06CA01

ATC

amitriptyline and psycholeptics; systemic

1.5

43.1

1541

10461

N05AH04

ATC

quetiapine; oral

1.4

42.9

2813

21406

ND2AA

NOMESCO Finland

Hand and fingers X-ray examination

1.5

42.9

1382

9163

D12.3

ICD-10 Finland

Benign neoplasm: Transverse colon

2.5

42.9

355

1447

Z94.4

ICD-10 Finland

Liver transplant status

6.6

42.8

113

173

M01AB55

ATC

diclofenac, combinations; oral

1.7

42.7

1021

6275

D12.2

ICD-10 Finland

Benign neoplasm: Ascending colon

2.2

42.6

437

1982

E000002

ATC

1.4

42.5

1945

13890

TJJ00

NOMESCO Finland

Percutaneous needle biopsy of liver

7.2

42.3

105

147

Z01.0

ICD-10 Finland

Examination of eyes and vision

1.4

42.3

2634

19870

1380

FHL

Colonoscopy, left side

17.9

42.1

M54.4

ICD-10 Finland

Lumbago with sciatica

1.4

42.1

2560

19242

G04CA02

ATC

tamsulosin; oral

1.3

41.9

3037

23472

R01BA52

ATC

pseudoephedrine, combinations; oral

1.3

41.9

4959

41005

P01BA02

ATC

hydroxychloroquine; oral

1.6

41.9

1251

8143

RD210

NOMESCO Finland

2.4

41.8

372

1573

4AC05

NOMESCO Finland

+∞

41.6

6410

FHL

Panprococolectomy and ileostomy

+∞

41.6

56906

ICD-8 Finland

Other diseases of intestines and peritoneum, Prolapsus ani

+∞

41.6

A41.9

ICD-10 Finland

Sepsis, unspecified

2.0

41.6

546

2749

J15.9

ICD-10 Finland

Bacterial pneumonia, unspecified

1.6

41.1

1285

8451

JK3MN

NOMESCO Finland

Bile absorbtion isotope examination

28.0

41.1

R52.9

ICD-10 Finland

Pain, unspecified

1.5

41.1

1319

8732

N03AE01

ATC

clonazepam; systemic

1.7

41.1

908

5458

SAA02

NOMESCO Finland

Basic examination of mouth

1.2

41.0

12355

112865

K91.2

ICD-10 Finland

Postsurgical malabsorption, not elsewhere classified

10.5

40.7

A46

ICD-10 Finland

Erysipelas

1.4

40.7

2037

14790

N06AB06

ATC

sertraline; oral

1.4

40.6

1799

12758

SFA10

NOMESCO Finland

Fillning on one surface of tooth

1.2

40.6

9784

87384

N18.9

ICD-10 Finland

Chronic kidney disease, unspecified

1.7

40.5

803

4670

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

3.0

40.4

244

824

SPAT1131

SPAT

Colonoscopy

2.1

40.4

503

2478

E87.1

ICD-10 Finland

Hypo-osmolality and hyponatraemia

1.9

40.3

595

3133

A04AA01

ATC

ondansetron; systemic, rectal

1.6

40.2

999

6199

SPAT1223

SPAT

Implementation of physical therapy rehabilitation plan

1.3

40.2

4529

37189

L88

ICPC

Rheumatoid/seropositive arthritis

1.9

40.1

583

3054

FM1EE

NOMESCO Finland

Extensive structural and functional ultrasound examination of heart

1.3

40.1

3136

24503

M79.7

ICD-10 Finland

Fibromyalgia

2.0

40.0

523

2632

A02BX02

ATC

sucralfate; oral

1.9

40.0

614

3280

JFG50

NOMESCO Finland

Laparotomy with revision of enterostomy or colostomy

28.4

39.8

R4190

NOMESCO Finland

Nutritional therapy

1.9

39.8

601

3193

127

Kela drug reimbursment

Transplant complication

2.6

39.6

296

1140

K73.2

ICD-10 Finland

Chronic active hepatitis, not elsewhere classified

5.9

39.6

113

192

SAA03

NOMESCO Finland

Extended examination of mouth

1.2

39.5

7052

61025

N30.0

ICD-10 Finland

Acute cystitis

1.4

39.4

2135

15718

N06AB10

ATC

escitalopram; oral

1.3

39.2

3400

26950

SPAT1312

SPAT

General health counselling

1.2

39.2

5695

48170

F32.10

ICD-10 Finland

Moderate depressive episode without somatic syndrome

1.5

39.1

1423

9685

WW500

NOMESCO Finland

Blood transfusion

1.9

39.1

611

3286

A02BA03

ATC

famotidine; systemic

1.9

39.0

590

3137

C01DA02

ATC

glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal

1.3

38.8

2692

20643

M46.1

ICD-10 Finland

Sacroiliitis, not elsewhere classified

2.8

38.8

255

910

Z03.3

ICD-10 Finland

Observation for suspected nervous system disorder

1.6

38.7

938

5781

K65.0

ICD-10 Finland

Acute peritonitis

3.2

38.7

212

670

K63.1

ICD-10 Finland

Perforation of intestine (nontraumatic)

3.8

38.6

167

438

XJW99

NOMESCO Finland

Other investigative procedure on digestive system

6.0

38.6

108

179

R29.8

ICD-10 Finland

Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems

1.5

38.5

1301

8715

NF1AE

NOMESCO Finland

Hip joint ultrasound examination

2.2

38.4

407

1872

R06AX27

ATC

desloratadine; oral

1.3

38.3

4707

39029

R05

ICD-10 Finland

Cough

1.3

38.3

3048

23860

KC1EE

NOMESCO Finland

Ultrasound measurement of residual urine

1.4

38.3

1762

12584

W01

ICD-10 Finland

Fall on same level from slipping, tripping and stumbling

1.3

38.2

4753

39462

M04AA01

ATC

allopurinol; systemic

1.4

38.2

1755

12535

R13

ICD-10 Finland

Dysphagia

1.6

38.1

923

5690

SPAT1230

SPAT

Aid fitting and borrowing and monitoring of use

1.4

37.9

2487

18895

I25.9

ICD-10 Finland

Chronic ischaemic heart disease, unspecified

1.5

37.9

1316

8865

L28

ICPC

Limited function/disability (L)

1.4

37.9

2190

16298

JHW96

NOMESCO Finland

Other operation on anus or perianal tissue

5.1

37.6

121

237

M79.1

ICD-10 Finland

Myalgia

1.4

37.5

2007

14732

TDM10

NOMESCO Finland

Puncture of maxillary antrum

1.8

37.5

627

3452

N05BA12

ATC

alprazolam; oral

1.5

37.5

1564

10956

F32.2

ICD-10 Finland

Severe depressive episode without psychotic symptoms

1.6

37.5

1097

7103

WX892

NOMESCO Finland

Monitored bed care

1.6

37.3

1139

7450

Z76.9

ICD-10 Finland

Person encountering health services in unspecified circumstances

1.5

37.2

1158

7608

A01

ICPC

Pain general/multiple sites

1.5

37.1

1159

7619

D07CA01

ATC

hydrocortisone and antibiotics; topical

1.4

37.1

2129

15817

K61.1

ICD-10 Finland

Rectal abscess

6.2

37.1

101

162

UGC12

NOMESCO Finland

Flexible bronchoscopy

1.6

37.0

1089

7057

R60.0

ICD-10 Finland

Localized oedema

1.5

37.0

1559

10943

SPAT1104

SPAT

Monitoring of emergency patient

1.6

36.9

1017

6484

K52

ICD-10 Finland

Other noninfective gastroenteritis and colitis

10.3

36.8

A28

ICPC

Limited function/disability NOS

1.4

36.7

1966

14432

K75.9

ICD-10 Finland

Inflammatory liver disease, unspecified

3.1

36.6

208

676

I84.9

ICD-10 Finland

Unspecified hemorrhoids without complication

1.7

36.5

716

4152

NH3AA

NOMESCO Finland

Foot and toes X-ray examination

1.5

36.5

1259

8472

Z71.8

ICD-10 Finland

Other specified counselling

1.3

36.3

4008

32763

K29.8

ICD-10 Finland

Duodenitis

3.6

36.3

166

457

R03AK07

ATC

formoterol and budesonide; inhalant

1.3

36.3

3055

24092

K02.1

ICD-10 Finland

Caries of dentine

1.2

36.2

10606

96068

SPAT1253

SPAT

Initiation, adjustment, discontinuation or repetition of medication

1.2

36.2

5349

45252

SPAT1260

SPAT

Consultation of another employee

1.3

36.2

2830

22083

R03AK06

ATC

salmeterol and fluticasone; inhalant

1.4

36.1

2130

15898

GD1DD

NOMESCO Finland

High resolution CT examination of lungs

1.7

36.1

709

4115

R07.3

ICD-10 Finland

Other chest pain

1.5

36.1

1381

9503

A03BA03

ATC

hyoscyamine; oral

3.5

36.1

171

485

M01AH05

ATC

etoricoxib; oral

1.2

35.9

10189

91994

K83.8

ICD-10 Finland

Other specified diseases of biliary tract

8.2

35.8

R03BA02

ATC

budesonide; inhalant

1.3

35.8

2836

22167

M51.3

ICD-10 Finland

Other specified intervertebral disc degeneration

1.5

35.6

1167

7758

L02.3

ICD-10 Finland

Cutaneous abscess, furuncle and carbuncle of buttock

2.2

35.6

364

1649

E000006

ATC

1.5

35.6

1108

7281

SFA20

NOMESCO Finland

Filling on two surfaces of tooth

1.2

35.5

10427

94399

Z01.2

ICD-10 Finland

Dental examination

1.2

35.4

7358

64466

5563A

ICD-9 Finland

Idiopathic proctocolitis, Ulcerative (chronic) proctosigmoiditis

+∞

35.4

R19.5

ICD-10 Finland

Other faecal abnormalities

2.8

35.3

241

880

M48.0

ICD-10 Finland

Spinal stenosis

1.4

35.3

1591

11312

WZA90

NOMESCO Finland

Other doctors statement

1.3

35.3

3933

32176

D07AB08

ATC

desonide; topical

1.4

35.2

1692

12181

A01AB04

ATC

amphotericin B; local oral

1.7

35.1

698

4062

SPAT1325

SPAT

Vaccination

1.2

35.1

5638

48102

C01CA24

ATC

epinephrine; parenteral

1.6

34.8

1005

6486

K25.9

ICD-10 Finland

Gastric ulcer, Unspecified as acute or chronic, without haemorrhage or perforation

2.5

34.4

280

1132

JFB30

NOMESCO Finland

Right hemicolectomy

2.8

34.3

233

850

L03

ICPC

Low back symptom/complaint

1.3

34.3

3878

31764

JJC00

NOMESCO Finland

Allogenic transplantation of liver

7.9

34.2

100

R02

ICPC

Shortness of breath/dyspnoea

1.4

34.2

1767

12887

JHD33

NOMESCO Finland

Completing incision of fistula-in-ano

6.7

34.0

132

NF1AA

NOMESCO Finland

Hip X-ray examination

1.5

33.8

1156

7760

ZX112

NOMESCO Finland

Subcutaneous

2.2

33.8

338

1516

WZC10

NOMESCO Finland

Extensive specialist consultion with written report

1.7

33.8

746

4481

A41.5

ICD-10 Finland

Sepsis due to other Gram-negative organisms

2.0

33.8

465

2388

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

1.5

33.7

1239

8449

A04

ICPC

Weakness/tiredness general

1.4

33.7

2052

15386

K60.2

ICD-10 Finland

Anal fissure, unspecified

2.4

33.7

283

1165

S01CA01

ATC

dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)

1.2

33.7

5218

44305

G47.3

ICD-10 Finland

Sleep apnoea

1.3

33.6

3187

25519

JFA45

NOMESCO Finland

Endoscopic contact coagulation in colon

4.8

33.5

113

234

D12.0

ICD-10 Finland

Benign neoplasm: Caecum

2.2

33.5

339

1531

A03

ICPC

Fever

1.3

33.5

2774

21806

N02CC01

ATC

sumatriptan; nasal, systemic, rectal

1.4

33.4

2172

16456

TKC20

NOMESCO Finland

Catheterisation of bladder

1.6

33.4

985

6388

DMB20

NOMESCO Finland

Functional endoscopic opening of maxillary antrum

1.6

33.2

822

5100

B02.9

ICD-10 Finland

Zoster without complication

1.7

33.1

782

4787

I50.9

ICD-10 Finland

Heart failure, unspecified

1.4

33.0

1717

12531

XF600

NOMESCO Finland

Bloodpressure measurement

1.6

33.0

968

6269

R03BB04

ATC

tiotropium bromide; inhalant

1.5

32.6

1347

9410

K85

ICD-10 Finland

Acute pancreatitis

2.4

32.5

279

1163

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

1.5

32.3

1126

7593

K83.9

ICD-10 Finland

Disease of biliary tract, unspecified

4.8

32.2

110

231

L88

ICD-10 Finland

Pyoderma gangrenosum

7.7

32.1

M81.4

ICD-10 Finland

Drug-induced osteoporosis

5.5

32.1

174

M02AA10

ATC

ketoprofen; topical

1.3

32.1

2373

18341

I25.1

ICD-10 Finland

Atherosclerotic heart disease

1.3

32.1

2865

22745

Z43.2

ICD-10 Finland

Attention to ileostomy

10.3

31.9

R31

ICD-10 Finland

Unspecified haematuria

1.4

31.8

1349

9475

XF603

NOMESCO Finland

Direct intraarterial blood pressure measurement

1.9

31.8

492

2639

D29

ICPC

Digestive symptom/complaint other

2.3

31.7

314

1404

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

1.6

31.7

759

4667

K90.4

ICD-10 Finland

Malabsorption due to intolerance, not elsewhere classified

9.9

31.6

K90.3

ICD-10 Finland

Pancreatic steatorrhoea

4.3

31.6

120

281

G43.9

ICD-10 Finland

Migraine, unspecified

1.6

31.4

909

5867

M01AC06

ATC

meloxicam; systemic, rectal

1.2

31.4

5768

49776

K92.0

ICD-10 Finland

Haematemesis

2.1

31.2

370

1792

UJF32

SPAT

2.5

31.2

257

1048

JHD00

NOMESCO Finland

Anal dilatation

3.5

31.2

149

427

WX290

NOMESCO Finland

Other blockade of nerve

1.2

31.1

8043

71656

R52.2

ICD-10 Finland

Other chronic pain

1.9

30.8

500

2727

6408

FHL

Colectomy and ileostomy

307.1

30.8

K63.9

ICD-10 Finland

Disease of intestine, unspecified

4.8

30.7

104

217

JN1BG

NOMESCO Finland

MRI examination of upper part of abodmen with high intensity magnet

3.2

30.7

168

533

R03BA01

ATC

beclometasone; inhalant

1.3

30.7

2140

16388

505

Kela drug reimbursment

Allergy to cow's milk in infants

9.0

30.6

S29

ICPC

Skin symptom/complaint other

1.3

30.6

2538

19933

E11.9

ICD-10 Finland

Type 2 diabetes mellitus, without complications

1.3

30.5

3192

25854

F33.10

ICD-10 Finland

Recurrent depression, moderate episode without somatic syndrome

1.6

30.5

879

5669

6402

FHL

Small bowel resection

9.2

30.4

L40.0

ICD-10 Finland

Psoriasis vulgaris

1.7

30.3

647

3848

QX2XE

NOMESCO Finland

Ultrsound examination of soft tissue not elsewhere classified

2.0

30.3

408

2080

XW000

NOMESCO Finland

Bone marrow biopsy

1.8

30.1

560

3195

R01AD58

ATC

fluticasone, combinations; inhalant, nasal

1.3

30.1

3418

27962

1470

FHL

Rectoscopy

3.5

30.1

146

424

B01AA03

ATC

warfarin; systemic

1.3

30.0

2693

21375

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

1.5

29.9

932

6122

E930A

ICD-9 Finland

Antibiotics[PENISILLIINIT]

18.4

29.9

ZJX00

NOMESCO Finland

Double balloon technique in gastroenterological endoscopy

9.1

29.9

M01AE02

ATC

naproxen; oral, rectal

1.2

29.9

10274

93708

I20.99

ICD-10 Finland

Angina pectoris, unspecified

1.6

29.8

870

5630

5761C

ICD-9 Finland

Other disorders of biliary tract, Cholangitis[CHOLANGITIS SCLEROSIVA]

82.6

29.7

J44.8

ICD-10 Finland

Other specified chronic obstructive pulmonary disease

1.4

29.5

1250

8773

FN1AC

NOMESCO Finland

Angiography of heart and/or coronary arteries

1.3

29.5

2846

22807

R05

ICPC

Cough

1.3

29.4

3531

29063

K74.3

ICD-10 Finland

Primary biliary cirrhosis

4.0

29.4

119

296

M75.1

ICD-10 Finland

Rotator cuff syndrome

1.3

29.4

3446

28284

JH1CM

NOMESCO Finland

Perianal extensive MRI with 3 Tesla magnet

14.9

29.4

B80

ICPC

Iron deficiency anaemia

2.2

29.4

315

1460

R74.0

ICD-10 Finland

Elevation of levels of transaminase and lactic acid dehydrogenase [LDH]

2.3

29.3

266

1139

XX6XT

NOMESCO Finland

Other intravascular therapy with radiological guidance

5.3

29.3

169

J01FA15

ATC

telithromycin; oral

1.4

29.3

1501

10921

TGC00

NOMESCO Finland

Bronchial lavation

2.0

29.2

364

1799

R33

ICD-10 Finland

Retention of urine

1.5

29.1

996

6684

L17

ICPC

Foot/toe symptom/complaint

1.2

29.1

3900

32511

K62.7

ICD-10 Finland

Radiation proctitis

4.6

29.0

103

226

NG1AA

NOMESCO Finland

Knee X-ray examination without contrast

1.4

28.9

1621

11980

R05FA02

ATC

opium derivatives and expectorants; systemic

1.2

28.7

6703

59060

D06AX01

ATC

fusidic acid; topical (antibiotics for topical use)

1.4

28.7

1545

11338

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

1.4

28.6

1295

9207

133

Kela drug reimbursment

Severe chronic pancreatic insufficiency

2.6

28.6

219

858

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

1.7

28.5

588

3462

SPAT1149

SPAT

Suture or treatment of traumatic wound

1.3

28.4

1861

14101

D07BA04

ATC

hydrocortisone and antiseptics; topical

1.4

28.4

1656

12317

F33.2

ICD-10 Finland

Recurrent depressive disorder, current episode severe without psychotic symptoms

1.6

28.4

734

4605

K60.1

ICD-10 Finland

Chronic anal fissure

2.1

28.3

344

1684

R05FB02

ATC

cough suppressants and expectorants

1.2

28.3

5949

51894

6525

FHL

Enterostomy occlusion

14.1

28.2

Z03.80

ICD-10 Finland

Observation for other suspected diseases and conditions

1.8

28.2

506

2854

R06AX13

ATC

loratadine; oral

1.3

28.1

2482

19647

J01DA06

ATC

[U] cefuroxime; systemic

1.3

28.0

2279

17834

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

1.8

28.0

537

3096

LC2BE

NOMESCO Finland

Transvaginal ultrasound examination of uterus, parametria and lower abdomen

1.2

28.0

4004

33597

Z93.3

ICD-10 Finland

Colostomy status

3.4

28.0

140

417

XX3DW

NOMESCO Finland

Time consuming IT work

1.4

27.9

1398

10123

138

Kela drug reimbursment

Severe anaemia associated with chronic renal failure

2.1

27.9

322

1544

B82

ICPC

Anaemia other/unspecified

2.1

27.9

333

1619

CJE20

NOMESCO Finland

Phakoemulsification with implantation of artificial lens in posterior chamber

1.2

27.8

3799

31717

B99

ICD-10 Finland

Other and unspecified infectious diseases

2.2

27.8

297

1378

JFA60

NOMESCO Finland

Stricturoplasty in small intestine

281.5

27.7

NE1AA

NOMESCO Finland

Pelvis X-ray examination

1.5

27.7

871

5732

E000003

ATC

1.6

27.7

708

4430

SPAT1222

SPAT

Counselling/guidance promoting independent living

1.3

27.7

2128

16520

UDH02

NOMESCO Finland

Rhinopharyngoscopy

1.5

27.6

969

6538

M70.6

ICD-10 Finland

Trochanteric bursitis

1.4

27.5

1578

11703

B01AC04

ATC

clopidogrel; oral

1.3

27.5

1977

15195

SHA01

NOMESCO Finland

Correction of physiology of bite - simple therapy visit

1.4

27.5

1626

12122

5604

FHL

Vascular preparation or cannulation in the operating room

6.5

27.5

111

NH3EA

NOMESCO Finland

Feet X-ray examination with load

2.1

27.4

319

1535

R03AC03

ATC

terbutaline; inhalant

1.3

27.4

2173

16938

D50.8

ICD-10 Finland

Other iron deficiency anaemias

2.5

27.4

225

916

Z50.1

ICD-10 Finland

Other physical therapy

1.6

27.3

771

4946

F33.11

ICD-10 Finland

Recurrent depression, moderate episode of somatic syndrome

2.0

27.3

362

1836

NB1AA

NOMESCO Finland

Shoulder X-ray examination without contrast

1.5

27.2

900

5993

NH3DA

NOMESCO Finland

Bilateral foot X-ray examination

2.0

27.2

335

1650

SPAT1125

SPAT

Stoma care and guidance

2.5

27.2

218

878

JN3DE

NOMESCO Finland

Abdominal extensive ultrasoudn examination with blood flow measurements after transplantation

3.8

27.1

116

304

JN2AE

NOMESCO Finland

Ultrasound examination of lower part of abdomen without contrast

2.7

27.1

192

721

L04AD02

ATC

tacrolimus; systemic (calcineurin inhibitors)

2.9

27.1

173

609

R96

ICPC

Asthma

1.4

27.0

1233

8774

45599

ICD-8 Finland

Haemorrhoids

2.0

27.0

356

1800

L20.9

ICD-10 Finland

Atopic dermatitis, unspecified

1.7

27.0

547

3206

XG412

NOMESCO Finland

Flow-volume spirometry with bronchospasmolysis

1.5

27.0

843

5543

A10AC01

ATC

insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)

1.4

26.8

1139

7995

T81.8

ICD-10 Finland

Other complications of procedures, not elsewhere classified

2.1

26.8

304

1446

K85.9

ICD-10 Finland

Acute pancreatitis, unspecified

2.2

26.8

276

1257

Z87.1

ICD-10 Finland

Personal history of diseases of the digestive system

1.2

26.8

7118

63332

JFK10

NOMESCO Finland

Freeing of adhesions in intestinal obstruction

5.3

26.8

158

JKA21

NOMESCO Finland

Laparoscopic cholecystectomy

1.4

26.7

1519

11246

J01CA08

ATC

pivmecillinam; oral

1.2

26.7

6350

55950

K60.4

ICD-10 Finland

Rectal fistula

7.0

26.7

F43.22

ICD-10 Finland

Adaptation disorder with mixed anxiety and depression

1.6

26.6

639

3935

N06AA12

ATC

doxepin; systemic

1.6

26.5

738

4720

JL5CG

NOMESCO Finland

Extensive MRI examinaiton of bile and pancreas ducts with high intesity magnet

3.0

26.4

158

533

M46.9

ICD-10 Finland

Inflammatory spondylopathy, unspecified

2.6

26.3

200

783

TPX10

NOMESCO Finland

Implantation of vascular injection port

1.9

26.1

413

2234

K86.1

ICD-10 Finland

Other chronic pancreatitis

3.0

26.1

152

505

M03BA52

ATC

carisoprodol, combinations excl. psycholeptics; oral

1.7

26.0

506

2928

C03DA01

ATC

spironolactone; oral

1.4

25.9

1401

10284

E27.3

ICD-10 Finland

Drug-induced adrenocortical insufficiency

4.2

25.9

235

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

1.5

25.8

1045

7266

F45.4

ICD-10 Finland

Persistent somatoform pain disorder

2.2

25.8

254

1136

D70.82

ICD-10 Finland

Drug-induced neutropenia

2.3

25.8

237

1025

D93

ICPC

Irritable bowel syndrome

2.6

25.8

188

719

F51.0

ICD-10 Finland

Nonorganic insomnia

1.3

25.7

1999

15534

7200A

ICD-9 Finland

Ankylosing spondylitis and other inflammatory spondylopathies, Ankylosing spondylitis

4.6

25.7

196

R03AC12

ATC

salmeterol; inhalant

1.6

25.6

629

3891

NA1BG

NOMESCO Finland

Cervical spine MRI examination with high intensity magnet

1.6

25.6

736

4742

R06AE09

ATC

levocetirizine; oral

1.3

25.5

2316

18384

I26.9

ICD-10 Finland

Pulmonary embolism without mention of acute cor pulmonale

1.6

25.4

696

4431

KH1AD

NOMESCO Finland

CT of urinary organs

1.8

25.4

469

2672

JJ9AE

NOMESCO Finland

Ultrasound examination of liver transplant

7.7

25.3

SFA30

NOMESCO Finland

Filling on tree or more surfaces of tooth

1.2

25.3

6574

58307

ND2DA

NOMESCO Finland

Bilateral hand X-ray examination

2.1

25.3

297

1435

G43.0

ICD-10 Finland

Migraine without aura [common migraine]

1.5

25.2

854

5719

206

Kela drug reimbursment

Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease

1.3

25.2

2329

18533

JFA55

NOMESCO Finland

Other endoscopic procedure using diathermy or heat in colon

4.9

25.1

170

SFA00

NOMESCO Finland

Small filling

1.3

25.1

1960

15241

N02AC04

ATC

dextropropoxyphene; oral

1.7

25.1

506

2965

ZXA00

NOMESCO Finland

Right side

1.2

25.0

4035

34233

WX320

NOMESCO Finland

Spinalanesthesy

1.2

25.0

3332

27700

K57.9

ICD-10 Finland

Diverticular disease of intestine, part unspecified, without perforation or abscess

2.0

25.0

316

1573

ZXA10

NOMESCO Finland

Bilateral

1.3

25.0

2755

22410

A12BA01

ATC

potassium chloride; oral

1.7

24.9

582

3552

J20

ICD-10 Finland

Acute bronchitis

1.4

24.9

1362

10012

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

1.4

24.9

1370

10081

R05DA20

ATC

opium alkaloids and derivatives - combinations

1.2

24.9

4201

35796

K63.2

ICD-10 Finland

Fistula of intestine

8.3

24.9

AN1

Coronary angiography

1.4

24.9

1479

11028

B25.8

ICD-10 Finland

Other cytomegaloviral diseases

5.9

24.9

119

K29.9

ICD-10 Finland

Gastroduodenitis, unspecified

2.9

24.9

156

545

ICD-10 Finland

1.9

24.8

357

1868

Z01.9

ICD-10 Finland

Special examination, unspecified

1.5

24.6

779

5137

NA2AA

NOMESCO Finland

Thoracal spine X-ray examination without contrast

1.9

24.6

352

1840

K62.6

ICD-10 Finland

Ulcer of anus and rectum

2.9

24.6

154

537

F33.9

ICD-10 Finland

Recurrent depressive disorder, unspecified

1.6

24.6

631

3954

R20.2

ICD-10 Finland

Paraesthesia of skin

1.5

24.5

954

6579

M81.9

ICD-10 Finland

Osteoporosis, unspecified

1.7

24.5

474

2738

D07BC01

ATC

betamethasone and antiseptics; topical

1.3

24.5

1757

13487

D17

ICPC

Incontinence of bowel

3.3

24.4

125

380

123

Kela drug reimbursment

Chronic disorders of vitamin D metabolism

2.0

24.4

327

1668

EP1AE

NOMESCO Finland

Neck ultrasound examination

1.5

24.3

777

5138

JJ5AT

NOMESCO Finland

11.5

24.3

S01GX01

ATC

cromoglicic acid; ophthalmic

1.2

24.3

3203

26590

R60.9

ICD-10 Finland

Oedema, unspecified

1.6

24.3

631

3964

S01BA01

ATC

dexamethasone; ophthalmic (corticosteroids, plain)

1.7

24.2

519

3093

M54.6

ICD-10 Finland

Pain in thoracic spine

1.5

24.2

981

6824

5781A

ICD-9 Finland

Gastro-intestinal haemorrhage, Melaena[MELAENA]

5.0

24.2

156

K90.8

ICD-10 Finland

Other intestinal malabsorption

10.4

24.2

GD1AD

NOMESCO Finland

Thorax CT examination

1.7

24.1

561

3424

K90.9

ICD-10 Finland

Intestinal malabsorption, unspecified

4.5

24.1

191

N39.4

ICD-10 Finland

Other specified urinary incontinence

1.4

24.0

1025

7203

FM1AE

NOMESCO Finland

Standard cardiac ultrasound examination

1.3

23.9

2372

19036

SPAT1156

SPAT

Guidance concerning treatment of rash and skin

1.3

23.9

1963

15367

N05BB01

ATC

hydroxyzine; systemic

1.5

23.9

950

6581

L13

ICPC

Hip symptom/complaint

1.3

23.9

2079

16404

JDW98

NOMESCO Finland

Other transluminal endoscopic operation on stomach or duodenum

2.3

23.8

221

961

L98.4

ICD-10 Finland

Chronic ulcer of skin, not elsewhere classified

2.1

23.8

270

1286

NA6CG

NOMESCO Finland

Sacro-iliac joint extensive MRI examination with high intensity magnet

3.7

23.8

106

289

J31.0

ICD-10 Finland

Chronic rhinitis

1.4

23.8

1131

8110

78559

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Colica abdominalis NUD

1.8

23.7

448

2572

JKA20

NOMESCO Finland

Cholecystectomy

1.9

23.6

358

1914

T81.9

ICD-10 Finland

Unspecified complication of procedure

2.1

23.5

263

1246

R55

ICD-10 Finland

Syncope and collapse

1.4

23.5

1478

11120

Z00.0

ICD-10 Finland

General medical examination

1.2

23.4

2887

23777

K25.7

ICD-10 Finland

Gastric ulcer, Chronic without haemorrhage or perforation

2.8

23.4

153

549

AA1CG

NOMESCO Finland

Extensive MRI examination of brain with high intensity magnet

1.4

23.4

1136

8180

G43.1

ICD-10 Finland

Migraine with aura [classical migraine]

1.4

23.3

984

6900

JKE02

NOMESCO Finland

Transduodenal endoscopic incision of common bile duct orifice

2.4

23.3

203

858

L01

ICPC

Neck symptom/complaint

1.3

23.2

2003

15783

XG410

NOMESCO Finland

Flow-volume spirometry

1.6

23.2

587

3664

XPX99

NOMESCO Finland

Other diagnostic examination of periferal vessel

1.5

23.2

817

5519

XQ830

NOMESCO Finland

Exposure to foodstuff

8.6

23.1

NA3CG

NOMESCO Finland

Lumbar spine extensive MRI examination with high intensity magnet

1.6

23.1

555

3415

R01AD11

ATC

triamcinolone; nasal

1.4

23.1

1306

9656

R63.4

ICD-10 Finland

Abnormal weight loss

1.7

23.1

464

2717

K73.9

ICD-10 Finland

Chronic hepatitis, unspecified

4.7

22.9

166

N83.2

ICD-10 Finland

Other and unspecified ovarian cysts

1.4

22.8

1338

9951

JFH00

NOMESCO Finland

Total colectomy and ileorectal anastomosis

6.2

22.7

A03DA02

ATC

pitofenone and analgesics; systemic

2.0

22.7

278

1368

N18.8

ICD-10 Finland

Other chronic renal failure

1.9

22.7

354

1909

N20.1

ICD-10 Finland

Calculus of ureter

1.7

22.6

505

3049

SPAT1310

SPAT

Counselling related to known health issue

1.2

22.6

5286

46360

M06.9

ICD-10 Finland

Rheumatoid arthritis, unspecified

1.8

22.6

394

2206

JFB96

NOMESCO Finland

Other partial excision of intestine

12.5

22.5

T88.7

ICD-10 Finland

Unspecified adverse effect of drug or medicament

2.2

22.4

230

1049

TK800

NOMESCO Finland

Hemodialysis

2.0

22.4

307

1580

SPAT1097

SPAT

Recording of ECG

1.3

22.3

2016

15984

6455

FHL

Perianal fistula surgery

4.0

22.3

226

J01FA01

ATC

erythromycin; systemic

1.3

22.3

2271

18281

I80.3

ICD-10 Finland

Phlebitis and thrombophlebitis of lower extremities, unspecified

1.7

22.2

494

2978

JG1JB

NOMESCO Finland

Defekography with X-ray

3.0

22.2

128

424

JFF11

NOMESCO Finland

Laparoscopic loop enterostomy

5.8

22.2

109

K55.1

ICD-10 Finland

Chronic vascular disorders of intestine

7.7

22.1

R07.0

ICD-10 Finland

Pain in throat

1.4

22.1

915

6393

T78.4

ICD-10 Finland

Allergy, unspecified

1.5

22.0

685

4502

E11.8

ICD-10 Finland

Type 2 diabetes mellitus, with unspecified complications

1.4

22.0

1164

8508

E87.5

ICD-10 Finland

Hyperkalaemia

2.3

22.0

211

935

K55.2

ICD-10 Finland

Angiodysplasia of colon

3.7

21.9

254

K62.4

ICD-10 Finland

Stenosis of anus and rectum

5.2

21.9

131

56901

ICD-8 Finland

Other diseases of intestines and peritoneum, Perforatio intestini NUD

+∞

21.9

D07CC01

ATC

betamethasone and antibiotics; topical

1.3

21.9

1919

15154

N04BC05

ATC

pramipexole; oral

1.4

21.8

941

6626

Z01.4

ICD-10 Finland

Gynaecological examination (general)(routine)

1.3

21.8

2336

18919

N06AX03

ATC

mianserin; oral

1.5

21.7

655

4274

D12.4

ICD-10 Finland

Benign neoplasm: Descending colon

2.2

21.6

215

969

K29.6

ICD-10 Finland

Other gastritis

2.5

21.6

173

699

SHB00

NOMESCO Finland

Prepation and fitting of bite rail to mouth

1.3

21.6

1470

11194

R01AD05

ATC

budesonide; nasal

1.4

21.6

1131

8255

G04BD04

ATC

oxybutynin; oral, transdermal

1.5

21.6

716

4774

D02AE01

ATC

carbamide; topical

1.4

21.5

972

6906

J46

ICD-10 Finland

Status asthmaticus

1.8

21.5

379

2133

C03EA01

ATC

hydrochlorothiazide and potassium-sparing agents; oral

1.3

21.5

2053

16389

WX306

NOMESCO Finland

Lumbar epidural anesthesy

1.4

21.5

939

6628

ZXC86

NOMESCO Finland

Use of endoscopic device

3.5

21.5

101

289

NH1AA

NOMESCO Finland

Ankle X-ray examination without contrast

1.4

21.4

917

6450

H20.1

ICD-10 Finland

Chronic iridocyclitis

2.4

21.4

175

717

TPH90

NOMESCO Finland

Removal of fixed intravenous catheter

2.1

21.2

229

1070

M47.2

ICD-10 Finland

Other spondylosis with radiculopathy

1.5

21.2

807

5543

JFA70

NOMESCO Finland

Suture of small intestine

4.8

21.2

149

H05BA01

ATC

calcitonin (salmon synthetic); nasal, parenteral

1.7

21.1

426

2500

J45.8

ICD-10 Finland

Mixed asthma

1.7

21.1

435

2570

JN3CG

NOMESCO Finland

Extensive MRI examination of abdomen with high intensity magnet

3.2

21.1

110

341

A01AB10

ATC

natamycin; local oral

1.7

21.1

422

2470

D82

ICPC

Teeth/gum disease

1.2

21.1

5884

52315

NA2BG

NOMESCO Finland

Thoracal spine MRI examination with high intensity magnet

1.9

21.0

320

1711

K23.8*B37.8

ICD-10 Finland

Esophagitis caused by candidiasis

3.9

21.0

224

K75.4

ICD-10 Finland

Autoimmune hepatitis

6.4

21.0

-1

NOMESCO Finland

1.2

20.9

5918

52663

A29

ICPC

General symptom/complaint other

1.3

20.9

1534

11816

SPAT1138

SPAT

Guidance concerning bowel function

2.1

20.9

234

1112

XF402

NOMESCO Finland

ECG with work load test

1.3

20.9

1439

10980

GD1ED

NOMESCO Finland

Extensive high resolution CT examination of lungs

1.7

20.9

397

2289

78551

ICD-8 Finland

Symptoms referable to abdomen and lower gastro-intestinal tract, Symptomata abdominalis acuta NUD

1.7

20.7

394

2271

QBE15

NOMESCO Finland

Excision of other superficial lesion of skin of trunk

3.7

20.7

242

SFC01

NOMESCO Finland

Adjuvant procedure of filling therapy

1.2

20.6

4135

35733

JAD10

NOMESCO Finland

Repair of incisional hernia

2.9

20.6

126

435

A04.5

ICD-10 Finland

Campylobacter enteritis

2.8

20.5

136

494

6451

FHL

Dilatation

2.9

20.5

125

430

M50.1

ICD-10 Finland

Cervical disc disorder with radiculopathy

1.5

20.5

615

4006

X58

ICD-10 Finland

Exposure to other specified factors

1.3

20.5

2137

17241

SPAT1229

SPAT

Assessment of need for aid

1.4

20.5

1017

7349

Z03.5

ICD-10 Finland

Observation for other suspected cardiovascular diseases

1.4

20.5

1021

7385

A41.8

ICD-10 Finland

Other specified sepsis

2.2

20.5

221

1031

G04BD08

ATC

solifenacin; oral

1.5

20.5

828

5756

SDA02

NOMESCO Finland

Parodonthologic therapy

1.2

20.4

5367

47454

C08CA05

ATC

nifedipine; systemic

1.4

20.4

846

5909

T81.3

ICD-10 Finland

Disruption of operation wound, not elsewhere classified

1.9

20.4

319

1722

H57.1

ICD-10 Finland

Ocular pain

1.7

20.4

452

2722

Z01.1

ICD-10 Finland

Examination of ears and hearing

1.3

20.4

1935

15428

M53.1

ICD-10 Finland

Cervicobrachial syndrome

1.3

20.4

1557

12058

TQW40

NOMESCO Finland

Remowal of suture of skin

1.4

20.3

971

6972

M05BX04

ATC

denosumab; parenteral

1.6

20.3

568

3640

KA1AE

NOMESCO Finland

Kidney ultrasound examination

1.8

20.3

328

1791

WX704

NOMESCO Finland

Intubation

1.4

20.3

991

7141

I10

ICD-10 Finland

Essential (primary) hypertension

1.1

20.3

8565

78462

B34.9

ICD-10 Finland

Viral infection, unspecified

1.7

20.3

439

2627

B07.9

ICD-10 Finland

Verruca simplex

1.6

20.2

504

3135

A10AB05

ATC

insulin aspart; parenteral (insulins and analog. for injection, fast-acting)

1.4

20.2

1065

7780

Z98.8

ICD-10 Finland

LabWAS

↥

(ID) Name

N Cases

N Controls

-log₁₀(p)

cases

controls

unit

cases

controls

-log₁₀(p)

N cases

N controls

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

632

1183

5.45

318.26

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

628

1176

5.45

316.10

1.2

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

271

174

15.72

314.21

1.0

1.1

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1055

2986

3.64

312.64

2.0

1.5

g/l

0.7

0.8

0.63

844

2242

(3019069) Monocytes/100 leukocytes in Blood

15500

90171

2.95

307.65

11.9

6.0

8.6

8.5

7.93

14895

84514

(3003327) Ova and parasites identified in Stool by Light microscopy

2366

6403

3.98

307.65

1.8

1.7

—

(3042299) inFLIXimab [Mass/volume] in Serum or Plasma

1385

228

64.24

307.65

3.6

2.2

mg/l

8.5

6.3

5.57

1156

159

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

777

1557

5.11

307.65

1.8

1.2

titre

—

(3006504) Eosinophils/100 leukocytes in Blood

15439

89640

2.94

307.65

11.6

5.8

2.8

2.9

3.23

14818

83551

(3022145) Colonoscopy Study observation

10431

17085

9.87

307.65

1.9

1.2

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

14615

95825

2.30

307.65

7.7

5.9

umol/l

10.7

11.5

11.16

14012

90516

(40768804) Tissue Pathology biopsy report

10670

75669

1.72

307.65

2.4

2.0

—

(3013115) Eosinophils [#/volume] in Blood

16920

98836

3.29

307.65

11.6

5.8

e9/l

0.2

4.48

15622

86730

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

10398

73225

1.73

307.65

2.2

1.9

pmol/l

93.8

96.6

7.50

6166

38435

(3013650) Neutrophils [#/volume] in Blood by Automated count

17716

110231

3.18

307.65

14.0

8.7

e9/l

4.0

4.1

1.99

16279

95994

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

1859

4549

4.33

307.65

1.4

1.2

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

1290

3868

3.46

307.65

1.3

u/ml

273.0

256.4

1.03

774

2477

(3018010) Neutrophils/100 leukocytes in Blood

15525

91809

2.88

307.65

11.1

5.6

57.3

56.8

8.23

14921

85974

(3028026) IgM [Mass/volume] in Serum or Plasma

2841

10867

2.82

307.65

1.9

1.8

g/l

1.2

1.3

0.84

2655

9922

(3001604) Monocytes [#/volume] in Blood

16575

95146

3.28

307.65

11.4

5.6

e9/l

0.6

1.78

15160

82252

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1001

2047

5.05

307.65

1.7

1.4

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

9727

45099

2.91

307.65

3.6

2.1

mg/l

2.9

0.12

8785

38411

(40760892) CBC W Ordered Manual Differential panel - Blood

8064

42967

2.30

307.65

8.5

4.1

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

976

2031

4.96

307.65

1.7

1.4

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

20669

144094

3.75

307.65

14.5

6.8

u/l

77.4

78.2

1.48

20129

135414

(40766800) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ T-cells [Units/volume] corrected for background in Blood

1329

1814

7.68

307.65

1.2

1.1

iu/ml

1.6

1.9

0.27

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

7633

44871

2.01

307.65

1.4

1.3

u/ml

1.3

1.8

3.56

1945

12280

(3037522) Nuclear Ab [Titer] in Serum

5022

26131

2.16

307.65

1.6

1.3

titre

528.8

537.9

0.13

1241

5066

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

11675

82039

1.80

307.65

7.5

6.0

mmol/l

1.2

0.34

10795

74461

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

14142

76390

3.01

307.65

3.4

2.2

nmol/l

75.1

1262.2

0.50

13425

69126

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

10150

63041

2.04

307.65

4.5

3.2

u/l

31.8

33.6

1.71

9511

59870

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

10169

58110

2.28

307.65

3.7

2.5

u/l

56.9

58.0

1.27

9604

53549

(3021589) Normoblasts [#/volume] in Blood

12988

85061

2.12

307.65

15.5

9.0

e9/l

0.0

1.57

11289

69357

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

6024

33738

2.04

307.65

1.6

1.7

—

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

1690

3556

5.02

307.65

4.6

6.2

iu/ml

699.4

1517.3

0.89

207

525

(3024561) Albumin [Mass/volume] in Serum or Plasma

15886

76921

4.02

307.65

8.3

4.5

g/l

36.1

35.8

12.76

15255

71182

(3017143) Hepatitis C virus Ab [Presence] in Serum

5166

24671

2.38

307.65

1.6

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

1713

4930

3.66

307.65

1.5

1.4

ug/g

274.0

278.9

0.39

1038

2798

(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay

1335

4120

3.36

307.65

1.3

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

1773

5273

3.54

307.65

1.3

1.1

—

(3002030) Lymphocytes/100 leukocytes in Blood

15665

93242

2.88

307.65

11.7

5.8

28.2

28.5

4.43

15029

87006

(3007566) Smooth muscle Ab [Titer] in Serum

1751

5053

3.65

307.65

1.6

1.2

titre

80.5

130.8

2.44

186

477

(40768797) Stomach Pathology biopsy report

4855

24502

2.22

307.65

1.3

1.2

—

(3019309) Folate [Moles/volume] in Red Blood Cells

5413

32085

1.88

307.65

2.0

1.7

nmol/l

1178.9

1161.0

0.65

4032

24421

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

976

2028

4.96

307.65

1.7

1.4

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

12732

90626

1.84

307.65

8.4

6.6

mmol/l

1.2

1.43

10747

76570

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

5158

24210

2.43

307.65

3.0

2.6

21.9

23.0

5.91

4506

20674

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1003

2040

5.08

307.65

1.6

1.4

—

(3025159) Blasts/100 leukocytes in Blood

3723

13471

3.08

307.65

6.0

4.0

0.1

0.2

2.19

941

3234

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

22427

197600

2.56

307.65

25.1

12.7

mg/l

19.2

23.4

87.73

19821

153986

(3017181) Myelocytes/100 leukocytes in Blood

4089

14984

3.07

307.65

5.8

4.0

0.8

0.9

1.27

1172

4116

(42529406) Shigella sp [Presence] in Stool by Culture

1776

5291

3.54

307.65

1.3

1.1

—

(3034770) Mitochondria Ab [Titer] in Serum

1717

4943

3.66

307.65

1.6

1.2

titre

724.3

973.9

0.67

152

(42870588) Differential panel, method unspecified - Blood

12691

64089

3.03

307.65

10.4

5.7

—

(3021440) Promyelocytes/100 leukocytes in Blood

3897

14270

3.05

307.65

5.9

4.0

0.1

1.01

1090

3827

(3006315) Basophils [#/volume] in Blood

16633

95551

3.30

307.65

11.5

5.6

e9/l

0.0

1.94

15224

82573

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1627

3601

4.76

307.65

1.6

1.3

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

1759

5226

3.54

307.65

1.3

1.1

—

(3002179) Metamyelocytes/100 leukocytes in Blood

3852

13607

3.17

307.65

5.5

3.8

0.5

0.7

6.50

902

2955

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

3730

16580

2.47

307.65

3.3

2.3

g/l

0.2

9.38

3507

15419

(3001122) Ferritin [Mass/volume] in Serum or Plasma

12990

85737

2.09

307.65

3.9

2.8

ug/l

113.2

119.4

1.54

12294

79861

(3019198) Lymphocytes [#/volume] in Blood

16772

98494

3.22

307.65

11.5

5.6

e9/l

1.9

2.0

2.65

15521

86747

(3005719) IgG [Mass/volume] in Serum or Plasma

3410

14103

2.64

307.65

2.9

2.7

g/l

10.9

10.5

6.12

3184

12915

(3007164) IgA [Mass/volume] in Serum or Plasma

7149

38914

2.18

307.65

1.7

1.4

g/l

2.4

2.3

0.65

4745

23826

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

1222

234

54.84

307.65

2.9

2.0

au/ml

132.5

207.7

1.05

169

(40758558) Short blood count panel - Blood

7658

48130

1.86

307.65

9.8

6.7

—

(3048689) Calprotectin [Mass/mass] in Stool

13470

20614

13.26

307.65

6.0

1.3

ug/g

220.2

95.1

150.79

12353

15404

(3023368) Bacteria identified in Blood by Culture

7812

48124

1.91

307.65

5.2

4.2

—

(3032080) INR in Blood by Coagulation assay

10407

71966

1.77

307.65

9.3

8.3

inr

1.2

7.42

3477

20787

(3025941) Bacteria identified in Stool by Culture

3833

10481

4.14

307.65

1.5

1.2

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1015

2098

5.00

307.65

1.7

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

6323

11133

7.30

307.65

2.0

1.5

—

(3018418) pH of Serum or Plasma

8015

53155

1.75

307.65

5.0

4.0

7.4

0.02

1630

10098

(3037467) Urinalysis macro (dipstick) panel - Urine

16463

132417

1.74

307.65

5.4

4.1

—

(3004789) Transferrin [Mass/volume] in Serum or Plasma

5372

26210

2.34

307.65

2.9

2.4

g/l

2.4

0.59

5067

24213

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

627

321

19.99

307.65

2.1

1.3

au/ml

98.8

178.3

1.17

(3013707) Erythrocyte sedimentation rate by Westergren method

19338

140928

2.75

307.65

6.6

3.8

mm/h

12.5

11.3

27.38

18379

130650

(3025468) Yersinia sp identified in Specimen by Organism specific culture

977

2026

4.97

307.65

1.7

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

5753

28501

2.33

307.65

2.9

2.5

umol/l

12.8

13.4

7.37

5457

26368

(44786774) Adalimumab [Mass/volume] in Serum or Plasma

828

387

22.08

307.65

2.6

1.3

mg/l

9.4

9.1

0.49

702

291

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

3238

5120

7.12

307.65

1.7

1.6

iu/ml

3.2

5.3

0.25

697

1110

(3022096) Basophils/100 leukocytes in Blood

15198

86821

2.97

307.65

11.6

5.8

0.7

16.14

14580

80992

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

3337

17156

2.09

301.76

3.2

2.5

u/l

38.5

45.0

0.66

2940

14700

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

3883

21351

1.97

290.28

3.8

2.8

umol/l

7.2

8.3

2.82

3368

18427

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

673

1455

4.72

286.69

1.4

1.2

titre

268.7

138.7

0.81

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

673

1457

4.72

286.21

1.4

1.2

titre

240.5

160.4

1.71

223

185

(3009445) Proteinase 3 Ab [Units/volume] in Serum

1866

7670

2.55

285.62

1.6

u/ml

6.2

16.2

5.17

131

184

(46235355) HIV 1 and 2 tests - Meaningful Use set

6445

41968

1.72

276.21

1.8

1.9

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

13953

110408

1.61

273.58

6.2

4.6

mmol/l

6.6

6.7

3.69

13223

102405

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

1559

6014

2.70

271.10

1.8

1.6

titre

434.8

257.8

1.59

222

(3004716) Salmonella sp identified in Stool by Organism specific culture

2285

10533

2.29

270.31

1.4

—

(3036481) Cortisol [Moles/volume] in Serum or Plasma

3294

17567

2.01

266.98

2.4

2.2

nmol/l

348.4

375.2

10.95

3051

16156

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1342

4862

2.86

262.97

1.7

1.4

iu/ml

9.4

15.7

1.29

103

(3041672) Baker's yeast Ab [Presence] in Serum

162

37.01

261.48

1.1

1.0

—

(3035350) Ketones [Presence] in Urine by Test strip

12179

94335

1.57

253.13

4.4

3.4

estimate

0.0

1.54

3082

17108

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

5828

37667

1.72

252.96

2.1

1.6

pmol/l

31458685.1

31458306.1

0.00

5102

31299

(3009261) Glucose [Presence] in Urine by Test strip

12288

95458

1.57

251.51

4.5

3.5

estimate

0.0

0.50

3082

17100

(3048929) Epstein Barr virus Ab [Presence] in Serum

1696

7069

2.50

251.09

1.3

—

(3021601) Nitrite [Presence] in Urine by Test strip

12158

94567

1.56

244.88

5.8

4.7

estimate

0.0

3.27

3149

17589

(3031040) Bacteria [#/volume] in Urine by Automated count

15352

126018

1.58

242.81

5.5

4.2

e6/l

1445.9

1464.1

0.01

198

1767

(3033658) Prothrombin time (PT) actual/Normal

6982

47835

1.64

240.23

5.7

3.9

92.4

90.7

6.86

6807

46573

(3014148) Varicella zoster virus Ab [Titer] in Serum

854

2636

3.32

220.39

1.1

1.2

—

(3027945) Reticulocytes/100 erythrocytes in Blood

3419

19604

1.86

219.81

3.2

2.6

1.8

1.7

2.46

3047

17383

(3000850) Epithelial cells [#/volume] in Urine

5836

38983

1.65

218.29

3.0

2.6

e6/l

6.1

5.7

1.19

5240

33991

(3021960) Folate [Moles/volume] in Serum or Plasma

6038

40680

1.64

218.27

1.7

1.5

nmol/l

20.3

20.2

0.23

5355

35150

(3012095) Magnesium [Moles/volume] in Serum or Plasma

4661

29355

1.72

217.76

4.5

3.6

mmol/l

0.8

14.64

4347

27411

(3002582) Erythrocytes [#/volume] in Urine

7864

56477

1.58

217.58

3.8

3.2

e6/l

65.0

90.5

0.97

6350

42997

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

20351

180962

1.72

213.75

20.2

11.8

ml/min/173m2

85.9

84.5

14.16

17733

148077

(3030467) Casts [#/volume] in Urine by Automated count

7285

51586

1.58

213.30

3.7

3.1

e6/l

0.4

0.03

5766

38441

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

873

2810

3.18

210.17

1.1

—

(36304419) Bacteria [Presence] in Urine

7128

50555

1.58

205.68

3.6

3.0

—

(3020961) Endomysium IgA Ab [Titer] in Serum

1998

9754

2.14

202.65

1.2

1.1

titre

54.5

208.4

7.53

262

(3018095) Leukocytes [#/volume] in Urine

8932

66818

1.53

201.62

4.4

3.6

e6/l

82.5

89.3

0.31

6752

46491

(3003458) Phosphate [Moles/volume] in Serum or Plasma

3917

24010

1.75

199.74

7.3

6.1

mmol/l

1.0

1.1

1.76

3703

22406

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

823

2640

3.19

199.19

1.4

1.2

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

4527

28998

1.69

196.18

2.1

1.8

—

(3026782) Osmolality of Urine

5410

36270

1.63

196.12

3.2

2.7

mosm/kgh2o

536.9

551.0

4.44

4749

30900

(3042936) Bacteria identified in Isolate by Culture

4145

25987

1.71

194.36

2.4

2.0

—

(3029937) Albumin [Presence] in Urine by Test strip

7027

50398

1.55

189.77

5.0

3.8

estimate

0.0

0.30

3045

16898

(40761536) Microorganisms panel - Urine sediment

2840

16157

1.85

184.87

4.8

3.8

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

3610

22066

1.74

184.56

8.5

7.2

mmol/l

104.5

0.09

3542

21587

(3019550) Sodium [Moles/volume] in Serum or Plasma

21656

198013

1.79

180.40

22.5

14.7

mmol/l

139.4

139.6

44.63

21226

192793

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

9510

73294

1.48

179.72

4.7

3.6

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

21689

198610

1.79

176.92

22.7

14.8

mmol/l

3.9

4.0

35.63

21224

192962

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

8932

68137

1.49

176.87

4.1

3.4

ng/l

37.1

67.6

2.58

5841

43372

(3020564) Creatinine [Moles/volume] in Serum or Plasma

22482

208207

1.94

176.22

26.2

14.5

umol/l

77.8

76.1

9.87

22472

208118

(3023520) Reticulocytes [#/volume] in Blood

2573

14398

1.88

175.94

2.8

2.7

e9/l

71.7

69.8

1.55

1981

10761

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

1455

6628

2.27

174.53

1.3

1.4

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

1313

5883

2.30

163.57

4.5

3.3

u/ml

588.0

1639.4

1.08

1152

5018

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

423

992

4.32

162.40

1.5

1.4

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

427

1010

4.28

162.11

1.5

1.4

—

(3044640) Blood type and Crossmatch panel - Blood

7902

59646

1.48

161.01

3.0

2.3

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

8086

61353

1.47

160.26

3.5

3.3

mmol/l

2.3

2.4

12.42

7135

53799

(3002385) Erythrocyte distribution width [Ratio]

18685

166047

1.52

159.80

27.2

15.5

13.8

13.6

45.45

18483

162513

(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma

597

1801

3.37

159.53

1.3

1.2

u/l

58.5

68.1

1.53

420

1188

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

22479

209143

1.88

159.31

19.0

9.4

u/l

26.5

27.0

3.24

22146

202009

(3021879) Hepatitis B virus core Ab [Presence] in Serum

2722

16050

1.78

155.74

1.4

1.5

—

(3026008) Bacteria identified in Urine by Culture

7288

54502

1.48

154.09

3.6

3.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

11083

89711

1.43

153.11

5.0

3.9

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

334

681

4.95

152.43

1.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

7004

52103

1.48

151.53

4.1

3.1

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

289

527

5.53

149.59

1.2

—

(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma

711

2474

2.93

149.06

3.6

2.9

u/ml

31.5

745.2

1.12

697

2343

(3020779) Urea [Moles/volume] in Serum or Plasma

2697

16075

1.76

148.21

9.6

7.7

mmol/l

9.3

9.4

0.23

2565

15312

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

15512

133967

1.43

144.91

4.4

3.0

u/l

51.9

45.6

12.25

14674

125871

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

342

744

4.64

144.40

1.5

1.4

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

342

744

4.64

144.40

1.5

1.4

—

(36660697) Celiac disease serology panel - Serum

2710

16304

1.74

143.84

1.2

—

(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture

307

612

5.06

143.84

1.2

—

(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction

3218

20334

1.67

142.34

4.1

4.3

u/l

233.1

243.5

4.28

3041

19210

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

707

2519

2.86

141.89

1.1

g/l

1.5

0.52

662

2271

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

5808

42100

1.50

141.06

2.0

1.8

mg/l

1.2

0.25

4425

31612

(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

785

2991

2.67

138.50

3.3

u/ml

10790.9

1402.8

0.46

170

(3002032) Base excess in Venous blood by calculation

2787

17089

1.71

137.72

5.6

4.3

mmol/l

1.7

1.8

0.90

2243

13936

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

2804

17254

1.70

136.70

4.4

3.9

ug/l

22.5

24.8

0.15

2241

13759

(3012544) pH of Venous blood

2847

17677

1.69

134.04

5.5

4.3

7.4

0.68

(3004809) Band form neutrophils/100 leukocytes in Blood

751

2849

2.68

133.62

3.2

3.3

1.1

1.5

1.92

578

2219

(3021447) Carbon dioxide [Partial pressure] in Venous blood

2773

17146

1.69

132.51

5.6

4.3

kpa

5.8

1.09

2682

16617

(40768441) Liver Pathology biopsy report

453

1292

3.55

132.06

1.7

1.4

—

(3010375) cycloSPORINE [Mass/volume] in Blood

346

818

4.27

131.45

23.3

28.7

ug/l

123.2

120.1

0.29

300

678

(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay

212

326

6.54

130.63

1.3

1.2

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

3084

19833

1.63

126.09

2.0

1.7

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

3068

19715

1.63

125.80

2.0

1.7

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

287

609

4.75

124.93

1.9

u/ml

3734.4

47518.0

1.24

(3007853) Bacteria identified in Skin by Aerobe culture

3419

22671

1.59

122.86

2.0

1.7

—

(3017732) Neutrophils [#/volume] in Blood

2224

13303

1.74

119.25

3.1

2.7

e9/l

4.2

4.1

0.89

1657

10529

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

940

4178

2.30

118.76

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

6041

45367

1.44

118.44

3.0

2.3

—

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

1476

7804

1.95

118.05

1.8

1.7

g/l

1.5

0.40

1281

6661

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

488

1564

3.16

118.04

2.2

1.2

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

373

1008

3.74

117.83

1.4

1.2

u/l

86.9

87.8

0.05

322

870

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

931

4158

2.28

116.27

1.4

1.5

u/ml

22.9

21.1

0.10

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

363

985

3.72

114.00

1.4

1.2

u/l

23.8

21.8

0.26

309

831

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

1883

10879

1.79

113.68

1.1

—

(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma

376

1047

3.63

113.66

1.7

1.5

u/l

5.6

6.1

0.26

215

490

(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay

147

179

8.25

111.48

2.3

1.6

mg/l

2.0

1.6

1.87

130

153

(3016724) Homocysteine [Moles/volume] in Serum or Plasma

427

1313

3.29

110.61

1.6

1.4

umol/l

11.6

12.1

1.06

419

1233

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

4415

31618

1.48

109.77

3.1

2.7

e6/l

1.1

1.2

0.55

2642

17715

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

7028

54867

1.39

108.45

2.4

2.1

u/l

198.5

215.0

0.47

6680

51471

(3052851) Hemolysis interference index of Serum or Plasma

1126

5571

2.07

108.45

3.4

3.1

—

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

864

3852

2.29

108.28

1.5

u/ml

108.7

112.7

0.42

188

818

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1273

6586

1.98

108.26

2.1

2.0

ug/l

3.6

2.2

0.64

1140

5809

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

4318

30930

1.48

106.89

1.3

u/ml

10.3

11.6

0.43

1679

12138

(3014111) Lactate [Moles/volume] in Serum or Plasma

2493

15807

1.64

106.67

7.7

7.3

mmol/l

1.3

1.4

0.85

2389

15194

(3000991) Gas panel - Venous blood

2465

15665

1.64

104.38

9.6

8.6

—

(40761511) CBC panel - Blood by Automated count

21952

206473

1.59

103.32

20.3

12.0

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

323

868

3.75

102.90

2.7

2.0

umol/l

2.0

1.9

1.86

307

820

(3024354) Oxygen [Partial pressure] in Venous blood

2261

14158

1.66

101.35

4.7

3.8

kpa

4.6

4.7

0.89

2179

13668

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

4512

32943

1.45

100.37

1.3

iu/ml

25.6

35.8

3.76

1349

10141

(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence

774

3407

2.31

99.90

1.2

titre

160.0

168.1

0.04

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

952

4576

2.12

98.88

1.2

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

1120

5783

1.98

95.58

1.7

g/l

0.2

0.30

1060

5500

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

1142

5970

1.95

93.99

1.7

g/l

1.2

1.17

1086

5694

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

4080

29648

1.45

92.11

3.3

2.9

e6/l

3.1

2.7

1.06

2325

15853

(3008898) HLA-B27 [Presence]

1291

7094

1.86

91.25

1.1

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

2710

18171

1.55

90.59

4.0

3.3

—

(3000494) Fungus identified in Specimen by Culture

3150

21848

1.50

89.87

1.6

1.4

—

(3007628) Bicarbonate [Moles/volume] standard in Venous blood

1594

9405

1.74

88.72

5.9

4.9

mmol/l

24.0

24.1

0.94

1447

8537

(3015171) Extractable nuclear Ab [Units/volume] in Serum

1338

7525

1.82

87.69

1.3

1.2

u/ml

0.6

1.0

0.77

676

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

727

3295

2.24

87.46

4.4

3.3

u/ml

141.6

871.1

2.74

669

3013

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

16708

151113

1.33

86.60

4.3

3.9

pmol/l

14.8

14.7

2.04

15374

138107

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

308

902

3.44

86.28

1.1

miu/ml

1592.1

1477.8

0.92

308

902

(3028192) IgG subclass 2 [Mass/volume] in Serum

510

1987

2.60

85.91

1.3

1.4

g/l

2.9

0.03

342

1405

(3024139) IgG subclass 3 [Mass/volume] in Serum

510

1987

2.60

85.91

1.3

1.4

g/l

0.4

0.69

342

1405

(3017354) Segmented neutrophils/100 leukocytes in Blood

467

1741

2.71

85.91

3.2

3.3

58.8

57.7

0.42

290

1126

(3027135) IgG subclass 1 [Mass/volume] in Serum

509

1988

2.59

85.31

1.3

1.4

g/l

7.0

6.7

0.50

345

1400

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

1920

12044

1.64

84.78

5.0

4.0

kpa

5.1

3.19

1788

11174

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

374

1247

3.03

84.57

1.1

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

394

1361

2.92

83.65

1.1

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

374

1256

3.00

83.51

1.1

—

(4062490)

506

1992

2.57

83.44

1.4

—

(3009343) pH of Capillary blood

1895

11904

1.64

83.14

5.0

4.0

7.4

0.72

261

1444

(3016502) Oxygen saturation in Arterial blood

2624

17785

1.53

83.03

8.7

7.8

95.9

95.7

0.47

2519

17098

(3003396) Base excess in Arterial blood by calculation

2889

19998

1.50

82.69

8.3

7.3

mmol/l

0.9

1.0

0.77

2247

15637

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

284

813

3.52

82.42

3.0

2.0

umol/l

27.7

28.4

0.52

278

785

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

2069

13327

1.60

81.88

4.5

4.0

ng/l

90.7

89.4

0.22

1839

11585

(3020630) Protein [Mass/volume] in Serum or Plasma

2155

14023

1.59

81.68

2.5

g/l

66.2

66.6

1.33

1973

12748

(4035726)

2335

15488

1.56

81.40

1.5

1.4

—

(3018677) aPTT in Platelet poor plasma by Coagulation assay

3828

28081

1.43

80.93

2.6

2.2

30.0

29.8

1.12

3720

27234

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

1880

11871

1.63

80.70

8.6

7.8

mmol/l

24.7

24.8

0.48

1861

11774

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

2873

19986

1.49

80.08

8.3

7.3

kpa

5.0

5.1

4.42

2724

19053

(3027801) Oxygen [Partial pressure] in Arterial blood

2871

19974

1.49

79.98

8.3

7.3

kpa

12.2

12.6

4.96

2721

19023

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

6057

47999

1.35

79.85

3.2

3.0

ng/l

1519.9

1343.7

1.70

5167

40663

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

1062

5724

1.89

79.55

1.1

u/ml

5.3

6.1

0.18

795

(3004588) Protein electrophoresis panel - Serum or Plasma

1798

11299

1.64

78.60

2.2

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1733

10808

1.65

78.06

1.6

1.5

—

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

1824

11536

1.63

77.67

5.0

4.0

mmol/l

1.5

1.6

0.50

1342

8460

(3011397) Hemoglobin [Presence] in Urine by Test strip

5617

44210

1.35

76.96

4.3

3.5

—

(3022217) INR in Platelet poor plasma by Coagulation assay

3162

22591

1.46

76.70

23.2

23.3

inr

1.3

0.44

498

3275

(3005322) IgE [Units/volume] in Serum or Plasma

1976

12841

1.58

75.04

1.4

1.3

u/ml

256.4

253.7

0.03

1833

11882

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

2192

14617

1.55

74.27

4.8

3.7

mmol/l

1.2

4.72

1977

12734

(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay

1063

5861

1.85

74.08

1.8

1.9

—

(3026493) Urate [Moles/volume] in Serum or Plasma

6080

48653

1.33

73.91

3.0

2.6

umol/l

3566.8

4066.2

0.45

5319

42463

(3002173) Hemoglobin [Mass/volume] in Arterial blood

2404

16404

1.51

73.14

9.2

8.1

g/l

119.7

122.1

6.60

2333

15809

(3030366) Cystatin C [Mass/volume] in Serum or Plasma

1002

5481

1.86

71.58

4.8

5.0

mg/l

1.5

1.4

1.17

927

5080

(3032057) Clostridioides difficile [Presence] in Stool

161

338

4.78

71.15

2.0

1.8

—

(3020717) Zinc [Moles/volume] in Serum or Plasma

294

944

3.14

70.99

2.1

1.5

umol/l

22.2

25.1

0.90

278

905

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

4234

32234

1.38

70.95

3.4

3.0

mmol/l

2.4

0.20

3670

28069

(3008757) Leukocyte morphology finding [Identifier] in Blood

475

1966

2.44

70.44

3.6

3.8

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

827

4315

1.95

68.22

1.7

—

(3010421) pH of Blood

889

4806

1.88

65.85

4.6

3.9

7.4

0.50

775

4102

(1616796) Gas panel - Central venous blood

784

4075

1.95

65.40

3.7

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

19203

179477

1.32

64.41

5.2

4.6

mu/l

1.8

2.1

7.40

17893

165758

(3046870) Tissue transglutaminase IgG Ab [Units/volume] in Serum

1343

8252

1.66

63.78

1.1

u/ml

18.0

7.7

0.39

109

(3023183) Ammonium ion [Moles/volume] in Plasma

739

3818

1.96

62.73

3.3

2.8

umol/l

32.7

34.1

0.96

645

3250

(3027315) Oxygen [Partial pressure] in Blood

796

4220

1.91

62.59

4.7

4.0

kpa

8.8

8.7

0.72

779

4121

(3012501) Base excess in Blood by calculation

792

4194

1.92

62.49

4.6

3.9

mmol/l

2.6

2.4

0.68

553

2774

(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma

374

1464

2.58

62.47

1.1

mg/l

287.4

0.00

340

1317

(3013290) Carbon dioxide [Partial pressure] in Blood

792

4196

1.91

62.40

4.7

3.9

kpa

5.0

0.47

775

4098

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

787

4189

1.91

61.13

1.8

1.7

—

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

998

5720

1.77

61.04

2.6

2.7

—

(40761535) Cells panel - Urine sediment

2135

14732

1.49

60.95

4.4

3.4

—

(3013512) EKG study

6225

51046

1.29

60.92

4.1

3.7

—

(3019060) Gas panel - Arterial blood

1718

11331

1.55

60.66

5.7

4.7

—

(3019225) pH of Specimen

2453

17443

1.45

59.96

4.7

4.1

—

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

4447

34902

1.33

59.78

4.2

3.6

ng/l

356.1

495.0

1.29

3215

25717

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

15242

138917

1.25

59.66

3.4

3.2

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1449

9239

1.60

59.19

2.4

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

618

3076

2.03

58.31

1.8

1.7

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1616

10612

1.56

58.10

4.8

3.7

g/l

127.6

129.8

3.27

1578

10365

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

226

708

3.21

56.96

3.4

2.7

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

1565

10270

1.56

56.39

1.8

1.7

—

(3019150) Specific gravity of Urine by Refractometry

5152

41781

1.29

53.72

4.8

3.8

kg/l

1.0

1.14

776

6262

(40767503) Oxygen content in Capillary blood by calculation

713

3837

1.88

53.53

2.7

2.5

16.4

16.5

0.42

363

1959

(3027273) Bicarbonate [Moles/volume] in Venous blood

1308

8338

1.60

53.37

4.9

3.5

mmol/l

24.9

25.2

2.08

1265

8082

(3008152) Bicarbonate [Moles/volume] in Arterial blood

1621

10852

1.53

53.25

8.2

7.0

mmol/l

24.2

24.6

2.71

1530

10101

(3020393) Adenovirus Ag [Presence] in Stool

120

258

4.66

51.64

1.5

1.4

—

(3016650) Hepatitis A virus Ab [Presence] in Serum

630

3296

1.93

51.54

1.1

—

(3007461) Platelets [#/volume] in Blood

22935

221888

1.50

51.21

34.4

18.8

e9/l

263.6

252.8

104.72

22637

216142

(3015235) Bicarbonate [Moles/volume] in Capillary blood

802

4545

1.79

50.92

4.0

3.2

mmol/l

24.2

24.6

1.56

699

3994

(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood

1211

7671

1.61

50.69

5.4

4.0

48.4

49.0

0.33

1198

7581

(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)

2085

14824

1.44

50.57

3.2

2.5

ml/min/173m2

67.6

68.3

0.35

900

5680

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

504

2454

2.07

50.52

1.6

1.5

—

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

1285

8274

1.58

50.18

4.0

3.3

1.3

0.40

1280

8229

(3035941) MCH [Entitic mass]

22940

222085

1.49

49.54

34.2

18.7

30.3

30.2

7.48

22781

219024

(3024731) MCV [Entitic volume]

22941

222106

1.49

49.42

34.3

18.7

91.1

90.5

64.11

22778

219043

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

616

3245

1.92

49.37

1.1

—

(3026361) Erythrocytes [#/volume] in Blood

22942

222135

1.49

49.21

34.4

18.8

e12/l

4.5

107.85

22594

215807

(3011412) CD3 cells [#/volume] in Blood

421

1932

2.20

49.18

2.4

2.6

e9/l

1.3

1.2

0.48

249

1172

(3010813) Leukocytes [#/volume] in Blood

22943

222186

1.49

48.74

34.4

18.8

e9/l

6.9

6.7

25.61

22608

215832

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

1254

8091

1.58

48.52

4.0

3.3

0.7

0.04

1213

7778

(3000963) Hemoglobin [Mass/volume] in Blood

22942

222221

1.48

48.19

34.6

18.9

g/l

133.9

136.2

107.05

22776

219181

(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma

246

890

2.78

48.12

1.1

u/l

23.0

25.2

0.13

205

680

(3014007) Fractional oxyhemoglobin in Arterial blood

1613

11031

1.49

47.70

10.1

9.5

93.9

94.0

0.35

1601

10991

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

707

3938

1.82

47.55

1.6

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

5083

41712

1.27

47.29

1.7

1.6

—

(3035062) Alkaline phosphatase.liver 1 [Enzymatic activity/volume] in Serum or Plasma

245

894

2.75

47.16

1.1

u/l

80.5

86.2

0.32

215

711

(3034860) Kappa light chains.free [Mass/volume] in Serum

868

5143

1.71

47.11

3.0

3.1

mg/l

116.2

53.2

0.47

691

4148

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

163

470

3.48

46.99

1.3

1.2

—

(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma

1228

7943

1.57

46.98

1.8

2.0

u/l

39.0

39.5

0.30

1072

7109

(3022313) Gas panel - Capillary blood

1329

8751

1.55

46.97

5.4

4.2

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

890

5329

1.69

46.47

1.8

1.7

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

865

5140

1.71

46.45

3.0

3.1

mg/l

36.3

46.0

1.66

685

4153

(40768443) Skin Pathology biopsy report

1244

8102

1.56

46.16

1.3

1.2

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1183

7618

1.58

46.12

2.2

2.0

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

843

4992

1.71

45.85

3.0

3.1

ratio

3.5

2.7

0.17

401

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

2048

14764

1.42

45.82

2.7

2.3

ug/l

5.8

7.5

4.58

1770

12808

(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum

874

5234

1.69

45.60

1.3

u/ml

28.9

40.0

0.89

317

(3028271) Lactate [Moles/volume] in Capillary blood

554

2895

1.93

45.51

2.2

1.9

mmol/l

1.7

0.07

542

2832

(3028626) Oxygen [Partial pressure] in Capillary blood

835

4947

1.71

45.33

5.5

4.3

kpa

8.5

8.6

0.66

776

4632

(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma

286

1155

2.49

44.88

2.7

3.3

nmol/l

105.7

136.9

0.91

279

1142

(3022806) Fractional oxyhemoglobin in Capillary blood

470

2333

2.03

44.74

2.0

1.8

89.8

89.9

0.13

461

2298

(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1015

6353

1.62

44.57

2.3

2.2

g/l

3.8

0.19

710

4541

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1016

6363

1.62

44.50

2.3

2.2

—

(3023150) Myeloperoxidase Ab [Units/volume] in Serum

542

2835

1.93

44.40

1.3

1.4

—

(3052592) Norovirus Ag [Presence] in Stool

127

321

3.97

44.38

1.6

1.3

—

(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

1016

6374

1.62

44.19

2.3

2.2

g/l

7.3

7.4

0.30

740

4770

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

956

5908

1.64

44.18

3.4

3.0

g/l

3.5

0.06

913

5617

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

801

4734

1.71

43.88

1.3

u/ml

8.9

5.9

0.35

494

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

811

4816

1.71

43.65

1.3

u/ml

9.5

8.4

0.21

134

749

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1583

11024

1.46

42.58

10.1

9.4

0.7

0.98

1567

10962

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

418

2027

2.08

42.42

1.7

1.6

—

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

928

5764

1.63

42.02

3.7

u/ml

0.3

1.51

529

3278

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

681

3899

1.77

41.76

1.3

1.2

u/ml

7.6

5.2

0.24

288

(3026250) Tacrolimus [Mass/volume] in Blood

238

915

2.61

41.41

40.9

36.4

ug/l

7.0

7.4

1.91

215

839

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1578

11044

1.46

41.33

10.0

9.3

1.4

0.61

1560

10974

(3004490) Bicarbonate [Moles/volume] standard in Capillary blood

1184

7823

1.54

41.12

5.6

4.4

mmol/l

24.5

24.7

1.94

1118

7277

(3018405) Lactate [Moles/volume] in Arterial blood

959

6047

1.61

40.83

4.5

4.2

mmol/l

1.4

0.20

936

5946

(3005715) Vancomycin [Mass/volume] in Serum or Plasma

460

2344

1.98

40.71

8.0

6.4

mg/l

12.0

11.3

2.62

416

2143

(44816559) Phosphatidylethanol [Mass/volume] in Blood

686

3974

1.74

40.38

1.3

1.4

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

554

3012

1.86

40.32

1.1

u/ml

2.1

3.3

2.31

192

1502

(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

948

5986

1.61

40.12

2.4

2.2

g/l

3.1

3.0

1.45

727

4662

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

568

3120

1.84

40.01

1.6

1.5

—

(3023420) DNA double strand Ab [Units/volume] in Serum

418

2075

2.03

39.83

1.5

1.6

iu/ml

33.5

32.7

0.04

103

(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis

941

5942

1.60

39.82

2.3

2.2

g/l

10.3

0.01

784

4989

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

668

3864

1.75

39.53

1.2

u/ml

32.0

17.2

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

1067

6958

1.56

39.30

6.6

5.0

0.9

0.13

1011

6500

(3044889) 12 lead EKG panel

14151

130508

1.20

39.19

4.0

3.5

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

1081

7075

1.55

39.18

6.5

4.9

1.7

0.07

1026

6604

(3020891) Body temperature

1064

6943

1.55

39.08

5.9

4.9

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

402

1987

2.04

38.78

3.1

3.3

nmol/l

6.1

9.4

0.52

385

1928

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1060

6937

1.55

38.42

2.0

1.8

—

(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis

862

5378

1.62

38.33

2.4

2.3

g/l

0.9

0.18

741

4626

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

1384

9580

1.47

38.32

11.8

9.8

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

441

2266

1.96

38.12

1.6

1.4

—

(40760888) Immunoglobulin light chains.free panel - Serum

664

3882

1.73

37.84

3.0

3.1

—

(3009871) Measles virus Ab [Titer] in Serum

187

666

2.82

37.80

1.7

—

(3012110) Lysozyme [Mass/volume] in Serum or Plasma

821

5084

1.63

37.62

1.9

2.1

mg/l

11.7

10.8

1.31

761

4749

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

301

1346

2.25

37.58

1.2

1.3

—

(3037756) Immunofixation for Serum or Plasma

594

3377

1.78

37.34

1.7

1.6

—

(3036489) Thrombin time

1106

7364

1.52

37.03

2.6

2.3

21.8

21.4

0.89

965

6395

(3010503) CD19 cells [#/volume] in Blood

260

1101

2.37

36.86

2.4

2.7

e9/l

0.2

0.3

0.62

253

1068

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

296

1326

2.24

36.81

1.6

1.5

—

(3003181) Sodium [Moles/volume] in Urine

531

2936

1.82

36.64

2.0

1.4

mmol/l

63.1

64.0

0.18

392

2350

(3005895) Myoglobin [Mass/volume] in Serum or Plasma

974

6328

1.56

36.46

2.5

2.3

ug/l

395.0

600.9

1.46

895

5901

(3009542) Hematocrit [Volume Fraction] of Blood

19459

185427

1.23

36.37

23.2

13.7

39.6

40.1

16.57

14131

139738

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

490

2657

1.86

36.01

1.6

1.4

—

(3047181) Lactate [Moles/volume] in Blood

878

5614

1.58

35.23

7.2

5.6

mmol/l

1.3

0.32

782

4958

(3021901) Oxygen saturation in Capillary blood

570

3259

1.76

35.16

3.5

2.9

—

(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood

310

1444

2.16

35.02

2.3

2.8

e6/l

501.4

526.2

0.39

263

1185

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

310

1445

2.16

34.96

2.3

2.8

e6/l

649.2

716.2

0.81

133

539

(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay

897

5790

1.57

34.55

3.4

2.7

190.7

183.2

1.71

838

5497

(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method

962

6322

1.54

34.20

2.8

91.6

92.0

0.19

904

5883

(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool

132

5.23

34.13

2.2

1.7

ug/g

183.7

173.1

0.18

114

(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection

275

1236

2.24

33.97

1.8

1.7

—

(3026389) Candida sp identified in Specimen by Organism specific culture

507

2837

1.80

33.66

1.4

1.3

—

(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis

765

4787

1.62

33.61

2.4

2.2

g/l

0.0

0.40

703

4358

(3006184) Hemoglobin [Mass/volume] in Capillary blood

680

4132

1.66

33.59

2.4

2.2

g/l

129.3

130.6

0.67

512

3012

(3036071) Salmonella sp Ab [Titer] in Serum

169

611

2.77

33.27

1.1

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

308

1461

2.12

33.24

2.2

2.3

—

(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis

783

4943

1.60

33.17

2.4

2.1

g/l

37.4

37.9

1.26

667

4243

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

275

1249

2.21

33.12

2.9

2.4

96.2

97.4

0.21

265

1161

(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood

297

1404

2.13

32.35

2.4

2.8

e9/l

0.2

3.49

262

1182

(3051651) Icteric interference index of Serum or Plasma

257

1152

2.24

31.98

4.0

3.9

—

(3017895) Helicobacter pylori Ab [Units/volume] in Serum

1066

7268

1.49

31.80

1.7

—

(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood

318

1557

2.05

31.57

2.1

2.3

11.4

13.4

1.76

153

813

(1175426) CD3 cells/100 lymphocytes in Blood

321

1583

2.04

31.26

2.2

2.3

73.4

72.4

0.65

308

1528

(3014218) Bicarbonate [Moles/volume] standard in Arterial blood

1312

9338

1.43

31.22

10.5

9.6

mmol/l

24.1

24.3

1.04

1217

8717

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

444

2446

1.83

31.07

1.6

1.4

—

(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum

643

3939

1.65

30.79

1.3

1.2

u/ml

37.9

45.4

0.57

383

(3034274) Bile acid [Moles/volume] in Serum --fasting

506

2920

1.75

30.27

2.4

2.3

umol/l

10.5

7.0

2.38

395

2151

(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis

704

4435

1.60

30.11

2.5

2.2

g/l

0.0

1.54

643

4019

(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis

695

4375

1.60

29.82

2.5

2.2

g/l

0.0

0.00

640

4007

(3051252) Vasoactive intestinal peptide [Moles/volume] in Serum or Plasma

115

5.22

29.65

1.5

1.4

pmol/l

17.8

20.0

0.26

(3043409) Potassium [Moles/volume] in Arterial blood

799

5229

1.54

28.96

4.6

4.4

mmol/l

3.8

3.9

1.56

748

4904

(3002256) Pathology report gross observation

2977

24174

1.26

28.61

1.3

—

(3037121) Protein [Mass/volume] in Urine

946

6450

1.48

28.22

3.8

3.3

g/l

0.3

1.58

499

2925

(21494815) CD4 cells/100 lymphocytes in Specimen

340

1775

1.93

28.18

2.3

2.4

46.1

41.0

0.90

220

(3004616) Nuclear Ab [Presence] in Serum

400

2249

1.79

26.24

1.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

551

3386

1.64

26.12

3.6

3.3

—

(3042733) HLA Ab [Presence] in Serum

169

693

2.45

25.90

3.8

4.8

—

(3023419) Bacteria identified in Sputum by Culture

382

2128

1.81

25.86

2.8

2.5

—

(3051611) Lipemic interference index of Serum or Plasma

356

1944

1.84

25.72

3.9

3.4

—

(3039162) Centromere protein B Ab [Units/volume] in Serum

413

2367

1.76

25.39

1.3

u/ml

39.4

54.8

0.78

153

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

295

1528

1.94

25.09

1.7

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

295

1528

1.94

25.09

1.7

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

295

1528

1.94

25.09

1.7

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

629

4057

1.56

24.38

1.4

1.3

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

629

4058

1.56

24.35

1.4

1.3

—

(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma

1250

9205

1.38

24.30

2.4

2.3

u/l

6687.7

5625.3

0.45

423

3596

(3030981) Hyaline casts [#/volume] in Urine by Automated count

1307

9713

1.36

23.99

3.1

2.7

e6/l

0.3

0.41

1266

9450

(3045414) Leukocytes [Presence] in Urine

1146

8356

1.39

23.67

2.0

1.8

—

(3029536) Hepatitis C virus RNA [Units/volume] (viral load) in Specimen by NAA with probe detection

204

946

2.16

23.50

1.4

1.6

iu/ml

3011747.3

2001844.3

—

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

354

1992

1.79

23.22

1.8

1.7

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

216

1031

2.10

23.11

1.6

1.5

ug/l

7.5

7.6

0.04

199

931

(3024891) Influenza virus A+B Ag [Presence] in Specimen

800

5491

1.47

23.10

1.2

1.1

—

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

308

1669

1.85

22.87

1.1

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

533

3371

1.59

22.51

1.7

1.6

—

(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma

435

2627

1.67

22.15

1.3

nmol/l

0.2

0.51

167

(3024928) Oxygen saturation in Venous blood

590

3835

1.55

22.13

4.2

4.0

—

(3045683) HLA typing for celiac disease panel - Blood or Tissue

250

1280

1.96

22.06

1.0

—

(44790047)

368

2129

1.74

21.96

1.7

1.6

—

(44790049)

368

2129

1.74

21.96

1.7

1.6

—

(44806118)

368

2130

1.74

21.92

1.7

1.6

—

(44790048)

368

2130

1.74

21.92

1.7

1.6

—

(3017315) Amylase [Enzymatic activity/volume] in Urine

212

1028

2.07

21.78

1.2

1.3

u/l

296.1

362.9

0.43

195

946

(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma

400

2377

1.69

21.66

1.3

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

432

2626

1.65

21.46

1.3

nmol/l

0.6

1.7

1.07

415

2534

(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood

138

568

2.43

21.08

2.6

3.4

—

(3021788) Differential panel - Synovial fluid

512

3260

1.58

21.05

1.6

1.5

—

(4010399)

1698

13371

1.29

20.69

1.4

—

(3049717) Cytology report of Urine Cyto stain

874

6230

1.42

20.62

2.4

2.6

—

(3042631) Mycobacterium sp identified in Specimen

386

2303

1.68

20.61

2.9

2.5

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

1817

14481

1.27

20.10

3.1

2.9

ng/l

223.5

195.4

1.39

1636

13108

(3039000) Anion gap in Blood

590

3923

1.51

19.97

8.9

6.5

mmol/l

11.5

11.2

0.95

544

3513

(3018572) Chloride [Moles/volume] in Blood

590

3924

1.51

19.95

9.0

6.5

mmol/l

105.2

105.1

0.03

544

3514

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

3145

26633

1.21

19.76

1.8

1.5

1.4

2.10

2723

23685

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

124

502

2.47

19.67

1.6

ug/l

9.8

8.9

1.15

124

502

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

272

1492

1.83

19.50

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

270

1478

1.83

19.49

1.2

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

272

1493

1.83

19.46

1.2

—

(3038026) Centromere Ab [Units/volume] in Serum

266

1450

1.84

19.46

1.2

u/ml

39.6

49.9

0.18

(3001186) Copper [Moles/volume] in Serum or Plasma

119

475

2.51

19.45

1.6

1.3

umol/l

16.9

16.8

0.06

110

423

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

208

1045

2.00

19.45

1.7

1.4

—

(3035637) Corticotropin [Mass/volume] in Plasma

409

2519

1.63

19.34

1.6

1.5

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

272

1496

1.83

19.34

1.2

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

270

1482

1.83

19.33

1.2

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

682

4705

1.46

19.24

1.4

—

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

313

1801

1.75

19.11

1.8

—

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

269

1481

1.82

19.07

1.2

—

(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma

155

704

2.21

18.91

1.3

1.2

g/l

0.3

0.55

119

565

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

1575

12440

1.28

18.71

3.4

3.3

pmol/l

4.5

2.20

1407

11091

(21494814) CD8 cells/100 lymphocytes in Specimen

157

725

2.17

18.40

2.1

—

(3009508) Creatinine [Moles/volume] in Urine

6404

57712

1.15

18.39

3.5

3.2

mmol/l

7.7

7.8

1.64

5475

48906

(3000475) Leukocytes [#/volume] in Synovial fluid

624

4275

1.47

18.27

1.8

1.6

e6/l

9059.8

14382.1

4.32

470

3097

(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum

258

1422

1.82

18.25

1.2

u/ml

24.7

43.8

0.89

105

(3028433) Virus identified in Specimen by Culture

146

657

2.23

18.24

1.2

—

(3041423) Sjogrens syndrome-A extractable nuclear 60kD Ab [Units/volume] in Serum

257

1417

1.82

18.16

1.2

u/ml

78.8

68.5

—

(3022493) Free Hemoglobin [Mass/volume] in Plasma

170

815

2.09

18.10

3.8

5.2

mg/l

4184.1

1687.4

0.60

132

594

(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma

120

499

2.41

18.00

1.1

1.2

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

474

3080

1.55

17.89

1.2

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

555

3741

1.49

17.64

1.6

1.5

—

(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay

120

504

2.38

17.62

1.1

1.2

92.0

92.3

0.03

120

497

(40762365) Oxygen content in Arterial blood by calculation

269

2.94

17.60

3.2

3.0

ml/dl

14.8

14.7

0.05

250

(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid

364

2234

1.64

17.51

1.7

1.6

54.6

56.8

0.46

230

1412

(3010370) Gastrin [Moles/volume] in Serum or Plasma

297

2.83

17.49

1.4

2.0

pmol/l

44.9

45.3

0.01

255

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

185

930

1.99

17.33

1.8

1.5

—

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

260

1461

1.79

17.28

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

1594

12737

1.27

17.21

1.2

—

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

169

826

2.05

17.12

3.0

3.5

—

(3012494) Peanut IgE Ab [Units/volume] in Serum

148

690

2.15

16.98

1.1

u/ml

3.6

9.0

0.58

411

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

183

927

1.98

16.80

1.7

1.5

—

(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay

245

1365

1.80

16.77

1.2

u/ml

4.7

9.6

0.74

(3020682) Albumin/Creatinine [Ratio] in Urine

5982

53985

1.14

16.47

4.4

4.0

mg/mmol

15.1

9.3

1.31

3933

34428

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

344

2116

1.63

16.43

1.3

1.2

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

377

2372

1.60

16.42

2.5

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

1667

13470

1.25

16.35

2.4

2.3

au/ml

21.7

23.3

0.19

827

(3012516) Albumin [Mass/volume] in Urine

5710

51393

1.14

16.33

3.5

3.3

mg/l

514.9

411.6

0.81

3791

32684

(3022621) pH of Urine by Test strip

1530

12244

1.26

16.31

3.3

2.8

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

248

1400

1.78

16.26

1.3

u/ml

0.8

1.2

0.54

101

614

(3035947) Staphylolysin Ab [Units/volume] in Serum

179

911

1.97

16.23

1.2

1.1

iu/ml

3.1

4.0

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

358

2232

1.61

16.20

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

181

926

1.96

16.17

1.9

2.0

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

181

926

1.96

16.17

1.9

2.0

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

181

926

1.96

16.17

1.9

2.0

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

181

927

1.96

16.12

1.9

2.0

—

(3011985) Renin [Units/volume] in Plasma

396

2533

1.57

16.08

1.6

1.5

mu/l

62.8

66.0

0.14

356

2259

(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood

203

1086

1.87

15.87

2.4

2.8

38.5

39.5

0.21

365

(3013727) Leukocytes other/100 leukocytes in Blood

130

592

2.20

15.85

3.6

48.5

51.8

0.99

125

570

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

127

575

2.21

15.71

2.3

1.9

—

(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma

138

646

2.14

15.71

1.3

1.2

108.7

110.5

0.30

115

583

(40761539) Cells [Type] in Urine sediment by Light microscopy

108

457

2.37

15.66

1.1

1.3

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

250

1434

1.75

15.54

2.0

1.7

—

(3000093) Morphology [Interpretation] in Blood Narrative

292

1752

1.67

15.41

1.2

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

466

3120

1.50

15.37

1.3

1.2

u/ml

4.6

3.8

0.39

192

1057

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

170

867

1.96

15.35

1.3

1.2

—

(3016038) Potassium [Moles/volume] in Urine

209

1147

1.83

15.09

2.1

1.3

mmol/l

33.9

35.1

0.28

184

984

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

2699

23082

1.19

14.96

1.5

1.4

—

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

808

6001

1.36

14.95

1.4

1.3

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

282

1694

1.67

14.83

2.7

2.9

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

222

1252

1.78

14.66

1.2

1.1

—

(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay

4.71

14.64

1.0

—

(3019473) Protein [Mass/volume] in Cerebral spinal fluid

679

4924

1.39

14.59

1.3

1.5

mg/l

506.4

512.7

0.12

641

4702

(3000492) Spirometry study

2297

19404

1.20

14.59

1.6

1.4

—

(3042585) Pyridoxine [Moles/volume] in Serum or Plasma

108

472

2.29

14.58

1.3

nmol/l

119.0

125.6

0.15

351

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

3053

26449

1.17

14.49

2.2

2.1

—

(3000330) Specific gravity of Urine by Test strip

1138

8924

1.29

14.32

3.9

3.3

—

(3011897) Casein IgE Ab [Units/volume] in Serum

420

2.36

14.31

1.4

1.3

u/ml

8.1

6.0

0.15

(3008295) Osmolality of Serum or Plasma

296

1830

1.62

13.94

1.4

1.5

mosm/kgh2o

279.1

280.8

0.57

233

1414

(3008037) Lactate [Moles/volume] in Venous blood

529

3707

1.43

13.86

4.5

3.1

mmol/l

1.5

1.6

1.86

520

3624

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

607

4365

1.40

13.74

1.3

1.4

mmol/l

3.8

3.7

0.63

568

4110

(3045424) Erythrocytes [Presence] in Urine

460

3147

1.47

13.69

1.6

1.5

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

748

5572

1.35

13.61

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

125

597

2.10

13.58

1.4

1.5

—

(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum

431

2.30

13.52

1.1

1.2

u/ml

6.6

8.3

0.17

317

(3027231) Wheat IgE Ab [Units/volume] in Serum

106

476

2.23

13.46

1.1

u/ml

1.2

3.0

—

(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood

164

867

1.90

13.39

2.2

2.4

29.8

28.4

0.57

155

830

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

313

1984

1.58

13.31

1.1

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

1511

12358

1.24

13.27

1.3

au/ml

53.4

47.5

0.32

499

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

3319

29126

1.16

13.27

2.3

2.2

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

410

2761

1.49

13.22

1.7

1.6

—

(3006245) CD3-CD19+ cells/100 cells in Blood

167

894

1.87

13.13

2.3

2.6

13.3

11.3

0.96

153

845

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

251

1514

1.66

13.07

1.3

mmol/l

2.0

0.04

232

1415

(21494434) Karyotype in Bone marrow

240

1431

1.68

13.06

1.2

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

264

1619

1.64

12.89

4.1

3.7

—

(3003329) Lymphocytes/100 leukocytes in Synovial fluid

273

1690

1.62

12.83

1.7

1.5

29.3

31.7

0.47

167

1051

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

443

3055

1.46

12.69

1.3

1.2

u/ml

3.7

3.9

0.13

217

1370

(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay

206

1188

1.74

12.67

1.7

1.5

u/ml

18.3

24.7

1.07

240

(3024932) HLA-DR beta [Type]

137

696

1.97

12.61

1.1

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

2595

22426

1.17

12.61

9.5

6.6

—

(3024471) HLA-A [Type]

139

711

1.96

12.55

1.0

—

(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine

334

2.43

12.53

2.6

2.7

mg/l

68.0

40.3

0.45

(3038515) Glucose [Moles/volume] in Venous blood

494

3488

1.42

12.46

4.5

3.2

mmol/l

7.4

7.6

0.81

486

3417

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

3623

32152

1.15

12.33

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

595

4351

1.37

12.23

1.5

1.6

e6/l

573.8

2050.3

1.04

482

3549

(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection

332

2.41

12.22

1.7

1.5

—

(21494890) Protein electrophoresis panel - 24 hour Urine

270

1688

1.60

12.22

2.0

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

594

4345

1.37

12.18

1.4

1.5

e6/l

32.6

32.2

0.01

453

3368

(3020485) Acetaminophen [Moles/volume] in Serum or Plasma

163

888

1.84

12.16

2.3

2.2

umol/l

125.9

143.1

0.35

451

(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method

336

2214

1.52

12.07

2.5

2.0

mg/l

27.4

26.2

0.13

580

(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma

341

2.38

12.00

3.1

4.8

u/l

123.8

44.3

0.98

123

(3011325) HIV 1+2 Ab [Presence] in Serum

3.91

11.93

1.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

206

1210

1.71

11.90

1.5

1.4

u/l

13.6

12.5

1.29

196

1172

(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma

1072

13308

0.80

11.72

1.4

—

(3028679) Herpes simplex virus Ab [Presence] in Serum

191

1107

1.73

11.59

1.1

1.2

—

(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum

195

2.82

11.54

1.3

1.2

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

17921

173808

1.11

11.45

5.9

5.3

mmol/mol

39.4

39.3

0.90

16788

161670

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

118

3.39

11.44

1.2

—

(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay

219

1323

1.66

11.40

1.1

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

204

1210

1.69

11.39

1.2

1.1

ratio

1.0

1.1

1.48

420

(3045142) Bone marrow Pathology biopsy report

295

1916

1.54

11.36

1.3

—

(3023511) Choriogonadotropin [Units/volume] in Urine

628

4689

1.35

11.33

1.5

1.3

—

(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis

278

2.48

11.27

5.2

ug/min

35.5

44.9

0.96

213

(3044290) Cell count panel - Cerebral spinal fluid

555

4072

1.37

11.21

1.4

1.5

—

(3034891) Synovial lining cells/100 cells in Synovial fluid

156

861

1.81

11.21

1.6

1.5

5.0

3.8

0.46

190

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

155

857

1.81

11.08

1.3

1.7

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

155

857

1.81

11.08

1.3

1.7

—

(3030313) Adrenal Ab [Titer] in Serum

200

2.75

11.03

1.1

—

(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay

173

992

1.75

10.94

3.2

1.8

139.1

139.8

0.04

163

930

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

346

2352

1.48

10.75

1.4

pmol/l

320.2

312.5

0.11

280

1820

(3020874) Milk IgE Ab [Units/volume] in Serum

231

1437

1.61

10.74

1.2

1.1

u/ml

5.7

2.2

0.93

115

474

(3004451) EKG impression Narrative

142

772

1.84

10.73

1.3

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

312

2082

1.50

10.63

3.1

2.3

—

(3011841) English Walnut IgE Ab [Units/volume] in Serum

257

2.49

10.55

1.1

u/ml

0.3

5.8

2.02

202

(3006270) Folate [Moles/volume] in Blood

240

1520

1.58

10.37

1.2

nmol/l

361.4

366.3

0.15

207

1293

(3000060) B lymphocytes [#/volume] in Blood

129

689

1.87

10.33

2.2

2.6

e6/l

271.7

394.8

0.53

386

(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma

187

1118

1.68

10.19

1.6

1.4

u/l

6.0

5.9

0.05

155

956

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

124

658

1.89

10.14

1.2

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

394

2.16

10.11

1.7

1.6

ug/l

0.4

0.62

260

(3017704) Immunofixation for Urine

151

854

1.77

10.05

1.6

1.5

—

(3023323) Follitropin [Units/volume] in Serum or Plasma

1247

10305

1.22

9.95

1.4

iu/l

25.7

26.2

0.22

1088

8786

(3019977) pH of Arterial blood

167

975

1.72

9.95

3.0

2.5

7.4

0.79

319

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

410

2922

1.41

9.92

1.1

121.8

116.9

2.23

378

2636

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

145

815

1.78

9.87

1.1

1.2

—

(40768446) Kidney Pathology biopsy report

144

808

1.78

9.86

1.9

1.7

—

(3003338) MCHC [Mass/volume]

17793

172952

1.10

9.70

28.6

16.2

g/l

332.0

333.0

38.71

17685

171523

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

211

1318

1.60

9.70

1.5

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

554

4161

1.34

9.67

2.4

2.1

—

(40757494) Bilirubin.total [Moles/volume] in Blood

166

976

1.70

9.66

2.9

2.3

umol/l

31.7

51.7

0.93

124

(3044941) Cell count panel - Synovial fluid

385

2728

1.42

9.64

1.5

1.4

—

(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay

470

2.02

9.55

1.5

1.2

108.7

106.2

0.24

448

(3008536) Aspergillus sp Ab [Presence] in Serum

352

2.19

9.50

2.2

2.3

—

(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay

451

2.04

9.48

1.2

77.1

74.1

0.22

123

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

1691

19676

0.85

9.46

1.6

1.7

—

(3044927) Protein electrophoresis panel - Urine

245

1595

1.54

9.43

1.2

—

(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay

424

3071

1.39

9.36

1.1

—

(4306422)

421

3050

1.39

9.28

1.2

—

(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum

231

2.47

9.27

1.0

u/ml

0.6

0.1

1.26

146

(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay

128

707

1.81

9.27

1.2

110.1

107.0

0.37

118

636

(3043681) Transitional cells [#/area] in Urine by Computer assisted method

104

3.27

9.25

1.2

u/field

1.6

1.1

0.91

(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay

132

738

1.79

9.18

3.3

1.9

163.2

162.9

0.01

123

699

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

139

791

1.76

9.11

1.1

1.2

—

(3001850) Coagulation factor XI activity actual/normal in Platelet poor plasma by Coagulation assay

452

2.01

9.07

1.3

1.2

87.2

84.8

0.19

128

(3043870) Heparin induced platelet Ab [Units/volume] in Serum

148

2.84

9.00

1.2

—

(4015189)

440

2.02

8.99

2.2

—

(4268621)

308

2125

1.45

8.96

2.4

2.3

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

847

6795

1.25

8.95

1.4

1.5

u/l

9.6

9.3

0.22

698

5499

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

418

3046

1.38

8.91

1.1

—

(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum

231

2.42

8.79

1.0

1.1

u/ml

2.2

2.4

0.04

126

(3003740) Influenza virus B Ag [Presence] in Specimen

477

3558

1.35

8.77

1.1

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

171

1042

1.64

8.74

1.3

titre

301.5

499.3

0.54

(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence

167

1012

1.65

8.72

1.3

titre

45.3

77.6

0.92

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

393

2.06

8.63

2.5

2.6

—

(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum

163

2.70

8.60

1.4

1.2

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

131

747

1.76

8.56

2.1

2.2

—

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

129

734

1.76

8.50

2.1

2.2

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

129

734

1.76

8.50

2.1

2.2

—

(3002523) Influenza virus A Ag [Presence] in Specimen

475

3561

1.34

8.46

1.1

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

1779

15394

1.17

8.46

2.3

2.2

nmol/l

12.2

12.5

0.78

1598

13740

(3016031) Almond IgE Ab [Units/volume] in Serum

159

2.70

8.44

1.0

1.1

u/ml

0.8

1.0

0.18

101

(1761482) Bacteria [#/volume] in Urine by Culture

577

4448

1.30

8.44

4.8

3.9

—

(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay

121

679

1.78

8.36

1.1

87.6

93.0

0.57

312

(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright

399

2.03

8.30

1.2

pmol/l

316.2

321.9

0.04

288

(3028371) Actinomyces sp identified in Specimen by Organism specific culture

172

2.62

8.29

1.1

—

(40761871) Peanut recombinant (rAra h) 3 IgE Ab [Units/volume] in Serum

226

2.39

8.24

1.0

1.1

u/ml

0.2

1.1

1.22

124

(3048402) Erythrocytes [#/area] in Urine sediment by Automated count

163

997

1.64

8.24

1.4

1.8

u/field

1.9

2.6

1.01

127

717

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

273

1876

1.46

8.16

2.3

2.5

nmol/l

20.9

20.2

0.45

261

1781

(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay

120

678

1.77

8.12

1.1

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

417

3086

1.36

8.11

1.2

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

271

1862

1.46

8.10

1.5

1.6

—

(3010254) Herpes simplex virus identified in Specimen by Organism specific culture

493

1.91

8.07

1.1

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

149

896

1.66

8.06

1.1

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

1639

14148

1.17

8.05

1.2

iu/ml

102.0

145.5

5.53

571

5328

(3043138) Epithelial cells.renal [#/area] in Urine by Computer assisted method

3.75

8.03

1.1

u/field

1.1

1.4

0.24

(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay

122

696

1.75

7.99

1.1

86.5

92.3

0.93

311

(3016018) Differential panel - Cerebral spinal fluid

307

2165

1.42

7.99

1.5

1.6

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

304

2141

1.42

7.97

1.1

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

18939

185124

1.10

7.96

4.5

4.2

mmol/l

5.9

1.62

17474

170146

(21494755) Public health laboratory ask at order entry panel

1982

22489

0.87

7.93

1.3

—

(3040151) Glucose [Moles/volume] in Capillary blood

305

2154

1.42

7.88

7.8

9.6

mmol/l

7.2

7.5

0.84

249

1752

(3013201) Beta-2-Microglobulin [Mass/volume] in Serum or Plasma

210

1379

1.53

7.86

1.8

mg/l

4.0

3.7

0.29

192

1305

(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting

501

3828

1.31

7.85

2.8

2.1

nmol/l

1.0

0.8

4.80

423

3217

(3010144) Erythrocytes [#/volume] in Synovial fluid

248

1686

1.47

7.85

1.4

e6/l

145155.1

108641.3

0.32

169

1157

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

381

2797

1.37

7.82

1.2

1.3

u/l

38.8

32.2

0.43

342

2434

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

445

3348

1.33

7.78

1.1

au/ml

14.0

11.3

0.25

220

(42528717) Cashew nut recombinant (rAna o) 3 IgE Ab [Units/volume] in Serum

264

2.23

7.75

1.1

u/ml

2.6

3.2

0.19

212

(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex

173

1092

1.59

7.72

1.2

—

(3036312) Salmon IgE Ab [Units/volume] in Serum

128

2.81

7.64

1.1

u/ml

2.8

2.1

0.16

(3016284) Epstein Barr virus nuclear Ab [Units/volume] in Serum

4.50

7.62

1.2

1.1

—

(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis

260

2.23

7.60

10.2

9.8

mmol/l

5.5

5.3

0.11

260

(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

186

2.47

7.59

1.2

1.5

—

(3029075) Extractable nuclear Ab panel - Serum

105

583

1.80

7.57

1.1

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

300

2.13

7.51

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

447

3387

1.32

7.46

1.3

1.2

—

(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

388

1.99

7.46

7.6

5.7

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

615

4861

1.27

7.45

1.8

1.9

iu/l

4.0

12.1

1.02

208

1818

(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum

156

971

1.61

7.40

1.2

1.1

u/ml

9.4

14.3

0.32

108

(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma

302

2.12

7.40

1.1

pmol/l

4.1

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

114

2.89

7.38

1.3

1.4

umol/24h

305.9

312.5

0.07

114

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

133

796

1.67

7.37

4.3

3.7

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

270

2.19

7.36

1.9

1.5

—

(3048879) Bone marrow aspiration report

474

1.88

7.33

1.7

2.0

—

(3014599) Egg white IgE Ab [Units/volume] in Serum

212

1417

1.50

7.33

1.1

u/ml

3.3

6.6

0.67

415

(3036603) Volume of Urine

186

1209

1.54

7.33

1.6

1.7

1655.9

2034.4

1.95

277

(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay

303

2168

1.40

7.30

1.1

94.3

95.8

0.40

286

2033

(3020123) Porphyrins [Interpretation] in Serum or Plasma

115

2.87

7.27

1.1

—

(3013293) Extractable nuclear Ab [Presence] in Serum

279

2.15

7.21

1.5

1.6

—

(3003694) ABO and Rh group [Type] in Blood

6071

56872

1.09

7.20

1.5

—

(3017937) Magnesium [Moles/time] in 24 hour Urine

4.04

7.05

1.3

1.2

—

(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum

140

860

1.63

7.03

2.5

2.3

ug/l

25.6

178.4

1.23

135

816

(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection

112

2.86

7.01

6.0

4.8

—

(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum

194

2.37

6.96

1.7

mg/l

1.5

1.9

0.29

127

(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid

155

981

1.58

6.90

1.2

1.3

48.4

66.6

1.13

112

(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

2.6

1.6

0.52

121

(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

2.0

1.0

0.43

119

(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

1.5

2.1

0.30

139

(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

1.7

3.0

0.87

134

(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

1.1

2.4

1.89

126

(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

0.6

1.2

1.45

130

(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

1.7

3.2

1.38

126

(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

2.5

4.2

1.49

123

(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum

189

2.38

6.88

1.7

mg/l

1.1

1.7

1.17

135

(3026692) Albumin [Mass/volume] in Peritoneal fluid

428

1.89

6.87

1.6

1.4

g/l

11.9

13.5

0.71

325

(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture

120

713

1.68

6.87

1.1

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

560

4433

1.27

6.74

1.3

—

(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection

197

2.33

6.74

1.9

3.6

—

(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum

431

1.88

6.73

1.1

—

(3003434) Protein [Mass/volume] in Pleural fluid

296

2145

1.38

6.66

1.4

1.5

g/l

30.7

33.4

2.89

265

1924

(3047189) Immunofixation for 24 hour Urine

123

742

1.66

6.66

1.7

1.8

—

(3023091) Interleukin 6 [Mass/volume] in Serum or Plasma

310

2.03

6.57

1.3

1.4

ng/l

50.8

380.1

0.65

200

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

264

2.12

6.54

1.3

1.5

nmol/l

7.0

211666.4

1.42

223

(3003633) Ovomucoid IgE Ab [Units/volume] in Serum

165

2.42

6.38

1.4

1.5

u/ml

2.8

9.8

0.93

143

(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum

157

1016

1.55

6.38

1.9

—

(3018133) Calcium [Moles/volume] in Urine

411

1.87

6.36

2.1

2.4

mmol/l

2.6

2.7

0.12

369

(3023709) Somatotropin [Mass/volume] in Serum or Plasma

124

760

1.63

6.34

2.4

2.9

ug/l

1.4

1.2

0.39

117

712

(42870531) Hazelnut recombinant (rCor a) 1 IgE Ab [Units/volume] in Serum

137

2.55

6.24

1.0

1.1

u/ml

28.9

18.1

0.41

114

(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum

496

1.77

6.12

1.8

1.9

u/l

30.2

37.9

0.31

444

(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood

312

1.99

6.11

2.4

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

209

1449

1.44

6.09

1.3

u/l

410.3

440.7

0.12

193

1376

(3045716) Anion gap in Serum or Plasma

121

745

1.63

6.09

2.7

2.5

mmol/l

9.2

9.3

0.03

547

(3033942) Copper [Moles/time] in 24 hour Urine

2.95

6.08

1.2

1.3

umol/24h

1.7

1.0

0.20

(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum

259

2.08

6.06

1.1

u/ml

0.0

0.2

1.07

166

(3016750) Collection duration of Urine

155

1013

1.53

6.05

2.3

2.2

min

511.4

500.1

0.63

114

780

(3035320) C reactive protein [Mass/volume] in Body fluid

205

1421

1.44

5.99

2.7

2.4

—

(3002331) Protein [Mass/volume] in Peritoneal fluid

377

1.88

5.99

1.4

g/l

23.8

29.0

0.66

293

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

247

2.10

5.99

2.0

1.6

—

(3036782) Glucose [Moles/volume] in Pleural fluid

217

1521

1.43

5.97

1.3

mmol/l

6.6

6.3

1.07

201

1391

(3012565) Volume of 24 hour Urine

142

914

1.55

5.94

1.9

2.1

2025.1

1991.3

0.14

132

815

(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum

196

1351

1.45

5.91

1.1

iu/ml

6.5

7.8

0.32

327

(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum

185

2.27

5.82

1.1

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

163

1087

1.50

5.81

1.1

nmol/l

2.7

6.3

0.76

214

(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum

140

905

1.55

5.76

1.2

—

(21494262) English walnut recombinant (rJug r) 3 IgE Ab [Units/volume] in Serum

143

2.45

5.74

1.0

u/ml

3.2

1.3

0.45

113

(3023199) Leukocytes [#/volume] in Pleural fluid

263

1920

1.37

5.73

1.4

1.5

e6/l

2743.9

2784.3

0.02

185

1383

(3017569) Oxygen content in Arterial blood

119

742

1.60

5.72

2.7

2.1

—

(40767665) Peanut recombinant (rAra h) 9 IgE Ab [Units/volume] in Serum

206

2.18

5.70

1.0

1.1

u/ml

0.8

0.5

0.28

117

(3003129) Base excess in Capillary blood by calculation

449

1.78

5.68

1.6

1.7

mmol/l

0.3

0.7

0.33

421

(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma

365

1.86

5.58

1.4

1.6

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

101

609

1.66

5.56

1.4

1.5

—

(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal

231

1661

1.39

5.53

1.4

1.3

nmol/l

1.5

1.4

0.42

209

1495

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

419

3286

1.28

5.53

1.4

u/l

25.3

25.2

0.01

345

2706

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

5173

48609

1.08

5.48

1.7

1.6

mmol/l

1.4

4.45

4389

41277

(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay

137

895

1.53

5.41

1.1

1.0

98.5

96.9

0.25

113

709

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

855

7246

1.18

5.37

1.3

miu/ml

213.2

226.1

0.43

341

3386

(3036670) Protein [Mass/volume] in Synovial fluid

527

1.69

5.27

1.2

g/l

39.9

39.4

0.17

271

(3030862) Granulocytes [#/volume] in Cerebral spinal fluid

597

1.64

5.21

1.2

39.9

18.5

1.16

(3000012) Reticulocyte production index

145

971

1.49

5.12

1.7

1.4

—

(3014271) Vancomycin [Susceptibility]

127

827

1.54

5.11

3.1

3.0

—

(3020047) Haemophilus influenzae B Ab [Mass/volume] in Serum

4.44

5.02

1.2

1.6

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

117

753

1.55

4.98

2.4

—

(3042010) Triglyceride [Moles/volume] in Pleural fluid

225

2.04

4.97

1.2

1.3

mmol/l

0.7

1.6

1.11

153

(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood

260

1.96

4.92

1.4

1.3

—

(3006576) Bicarbonate [Moles/volume] in Blood

103

646

1.59

4.90

6.5

6.3

mmol/l

24.6

25.0

0.40

592

(3046914) Granular casts [#/area] in Urine by Computer assisted method

4.06

4.88

1.5

1.4

u/field

0.7

0.6

—

(3027923) C peptide [Moles/volume] in Serum or Plasma

151

1031

1.47

4.87

1.5

1.6

nmol/l

1.3

1.2

0.25

120

821

(3051014) Leukocytes [#/area] in Urine sediment by Automated count

201

1447

1.39

4.84

1.7

2.0

u/field

1.8

1.9

0.16

103

624

(4027681)

188

1338

1.41

4.84

1.2

—

(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma

725

6121

1.19

4.80

1.9

1.8

—

(3029634) Reagin Ab [Titer] in Serum by VDRL

393

3119

1.26

4.77

2.2

2.1

titre

15.9

6.1

0.47

(42529582) MDA5 Ab [Presence] in Serum by Line blot

445

1.71

4.73

1.2

1.1

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

445

1.71

4.73

1.2

1.1

—

(3013637) Mi-2 Ab [Presence] in Serum

445

1.71

4.73

1.2

1.1

—

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

445

1.71

4.73

1.2

1.1

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

1483

13215

1.13

4.71

1.9

—

(3023436) Glucagon [Mass/volume] in Serum or Plasma

102

2.55

4.68

1.4

1.7

ng/l

197.6

194.9

0.07

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

275

2093

1.32

4.64

1.1

—

(3016244) Insulin [Units/volume] in Serum or Plasma

203

1478

1.37

4.59

3.4

mu/l

31.9

27.0

0.66

186

1396

(3009550) Parvovirus B19 IgG Ab [Titer] in Serum

121

800

1.51

4.59

1.2

1.3

—

(44816844) Macroprolactin [Units/volume] in Serum or Plasma

346

2721

1.27

4.55

1.5

1.7

—

(3001820) Epstein Barr virus nuclear Ab [Presence] in Serum

2.71

4.49

1.0

1.2

—

(3020191) Ethanol [Moles/volume] in Serum or Plasma

234

1751

1.34

4.46

1.6

1.5

promille

1.2

1.4

0.99

164

1331

(3005685) Amylase.salivary [Enzymatic activity/volume] in Serum or Plasma

2.58

4.44

1.2

1.1

u/l

107.7

48.6

0.48

(3010838) Calcium [Moles/time] in 24 hour Urine

133

905

1.47

4.41

1.6

mmol/24h

4.5

5.6

0.73

(3018851) Theophylline [Moles/volume] in Serum or Plasma

149

2.21

4.40

2.1

1.7

umol/l

50.7

45.3

0.35

149

(4024509)

226

1686

1.34

4.40

1.7

1.6

—

(3034426) Prothrombin time (PT)

108

704

1.53

4.39

1.3

1.2

—

(3035933) Granulocytes/100 leukocytes in Blood

100

641

1.56

4.38

1.4

1.8

—

(4034850)

709

6026

1.18

4.38

11.8

9.1

—

(3018001) Oat IgE Ab [Units/volume] in Serum

143

2.24

4.37

1.1

1.0

u/ml

6.3

0.2

—

(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method

2.61

4.37

1.2

1.1

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

284

2193

1.30

4.34

1.1

—

20.9

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

557

1.60

4.32

3.0

2.4

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

557

1.60

4.32

3.0

2.4

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

535

4443

1.21

4.29

1.9

pmol/l

198.8

198.6

0.01

510

4232

(3007368) IgG [Mass/volume] in Cerebral spinal fluid

229

1723

1.33

4.23

1.1

1.2

mg/l

40.7

40.8

0.01

186

1454

(3022475) Manganese [Moles/volume] in Blood

120

2.33

4.22

1.2

1.3

—

(3027456) Digoxin [Moles/volume] in Serum or Plasma

373

2993

1.25

4.18

3.2

3.1

nmol/l

0.8

0.27

288

2266

(1761868) Lipid panel - Serum or Plasma

6893

71821

0.94

4.17

2.8

2.6

—

(3023351) European house dust mite IgE Ab [Units/volume] in Serum

553

4622

1.20

4.16

1.2

1.1

u/ml

2.7

1.8

0.74

238

2016

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

486

1.63

4.13

1.2

1.1

—

(3004775) Volume in Urine collected for unspecified duration

190

1396

1.36

4.11

2.2

2.3

735.4

668.9

1.08

130

981

(3024474) Albumin [Mass/volume] in Cerebral spinal fluid

221

1663

1.33

4.09

1.0

1.1

mg/l

262.5

254.8

0.16

191

1478

(3003888) Timothy IgE Ab [Units/volume] in Serum

501

4158

1.21

4.07

1.1

u/ml

6.6

5.8

0.33

263

2286

(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells

427

1.66

4.06

1.2

—

(4211845)

139

972

1.43

4.03

3.3

3.0

—

(3010726) Horse dander IgE Ab [Units/volume] in Serum

473

3910

1.21

4.01

1.1

u/ml

2.5

0.03

132

1044

(3015076) Soybean IgE Ab [Units/volume] in Serum

174

1267

1.37

4.00

1.1

u/ml

0.5

1.0

0.69

203

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

159

1141

1.39

3.99

1.3

u/l

21.5

12.9

0.81

139

1058

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

625

1.54

3.97

1.1

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

152

1085

1.40

3.94

1.1

—

(3045788) Cell count panel - Pleural fluid

200

1493

1.34

3.93

1.4

1.5

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

230

1752

1.31

3.93

1.4

1.5

e6/l

61276.4

49545.9

0.17

133

1043

(3018840) Calcitonin [Moles/volume] in Serum or Plasma

157

2.10

3.90

1.9

3.0

pmol/l

2124.0

55.0

0.46

(3013336) Amino acids [Identifier] in Serum or Plasma

100

2.40

3.86

3.1

2.3

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

155

1115

1.39

3.85

1.1

—

(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma

512

4283

1.20

3.85

1.4

pmol/l

92.3

132.7

2.55

498

4166

(3021387) Prolactin [Units/volume] in Serum or Plasma

940

8251

1.14

3.84

1.6

mu/l

312.0

307.7

0.13

862

7463

(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal

2.77

3.83

1.0

—

(3008401) Mugwort IgE Ab [Units/volume] in Serum

478

3976

1.20

3.82

1.1

u/ml

1.6

1.1

0.50

224

1828

(37021550) Renin [Units/volume] in Plasma --upright

374

1.68

3.81

1.4

1.3

mu/l

88.0

96.4

0.08

274

(3044242) Glucose [Moles/volume] in Arterial blood

117

803

1.46

3.77

2.6

2.0

—

(3020876) Protein [Mass/time] in 24 hour Urine

199

1495

1.33

3.76

1.8

1.9

g/24h

1.5

1.2

—

(40765096) Chromosome analysis panel by Banding

492

1.59

3.73

1.3

1.1

—

(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay

2.50

3.69

1.2

—

(3002621) Streptococcal DNAse B [Units/volume] in Serum

224

1.87

3.65

1.1

—

(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid

519

1.56

3.63

1.1

—

(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid

527

1.56

3.63

1.1

—

(3007919) Fasciola sp Ab [Titer] in Serum

3.66

3.62

1.0

—

(3020491) Glucose [Moles/volume] in Blood

190

1427

1.33

3.62

1.9

1.8

mmol/l

7.0

6.6

1.07

138

1045

(44813793)

198

1497

1.32

3.60

1.1

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

185

1385

1.34

3.60

1.6

1.5

umol/l

71.6

70.4

—

107

(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma

1098

9781

1.13

3.59

2.5

3.3

u/ml

62.5

53.0

0.30

1065

9423

(3012441) Differential panel - Pleural fluid

217

1663

1.31

3.59

1.4

1.5

—

(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay

429

1.61

3.52

1.1

—

(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection

256

1.80

3.51

2.1

2.0

—

(3020650) Glucose [Presence] in Urine

500

1.56

3.50

1.7

1.4

—

(40768453) Hazelnut native (nCor a) 9 IgE Ab [Units/volume] in Serum

178

1.97

3.50

1.0

u/ml

0.8

1.6

0.53

126

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

251

1968

1.28

3.49

1.1

—

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

115

800

1.44

3.49

1.1

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

500

5893

0.84

3.46

1.5

1.4

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

501

5903

0.84

3.46

1.5

1.4

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

502

5907

0.85

3.42

1.5

1.4

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

187

1.92

3.40

1.5

1.3

nmol/l

18.8

14.9

0.69

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

499

5869

0.85

3.38

1.5

1.4

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

100

682

1.47

3.38

1.2

1.1

—

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

741

6462

1.15

3.37

1.8

1.7

nmol/l

40.7

40.3

0.14

723

6303

(3016330) Potassium [Moles/time] in 24 hour Urine

282

1.74

3.35

1.3

—

86.8

—

(3006462) Nitrate [Presence] in Urine

125

890

1.40

3.35

3.4

3.1

—

(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum

388

3209

1.21

3.35

1.1

iu/ml

49.7

3642.3

0.67

770

(3012215) Mononuclear cells/100 leukocytes in Synovial fluid

443

1.58

3.34

1.5

1.3

45.5

39.3

0.72

291

(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)

210

1.86

3.32

1.4

1.2

—

(3009015) Lactate [Moles/volume] in Synovial fluid

182

1.92

3.30

1.2

mmol/l

6.3

6.1

0.07

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

757

6624

1.15

3.29

1.5

1.4

—

(3002619) Bacteria identified in Specimen by Culture

398

1.61

3.29

1.3

1.2

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

406

4846

0.83

3.27

1.5

—

(3043410) Blood group antigens tested for on Red Blood Cells

502

1.53

3.24

1.8

—

(3023487) Leukocytes [#/volume] in Peritoneal fluid

623

1.48

3.24

2.4

2.0

e6/l

579.0

3307.0

1.10

415

(3025443) Phadiatop IgE Ab [Units/volume] in Serum

133

964

1.38

3.23

1.1

u/ml

15.6

9.4

0.52

168

(40766207) Peanut recombinant (rAra h) 8 IgE Ab [Units/volume] in Serum

156

1.99

3.22

1.0

1.1

u/ml

9.5

8.1

0.12

112

(3024263) Appearance of Synovial fluid

129

931

1.39

3.21

2.2

1.7

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

286

1.71

3.21

1.1

1.0

ug/l

80.5

79.8

0.04

235

(3035880) pH of Pleural fluid

121

865

1.40

3.19

1.2

1.3

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

230

1807

1.27

3.19

4.1

4.8

u/ml

149.8

101.7

0.29

577

(36303858) Crystals [Presence] in Urine

3.57

3.18

1.0

1.2

—

(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative

302

1.69

3.17

1.3

1.2

—

(3026480) Teichoate Ab [Titer] in Serum

157

1.97

3.17

1.0

1.1

—

2.3

—

(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

530

1.51

3.14

1.1

—

(3023383) Lactate [Moles/volume] in Pleural fluid

477

1.53

3.06

1.4

1.3

mmol/l

3.7

3.4

0.25

434

(3019768) Coxiella burnetii Ab [Presence] in Serum

112

2.14

3.04

1.0

1.1

—

(3025130) Human papilloma virus identified in Specimen

331

2725

1.22

3.03

1.9

1.7

—

(3009613) Erythrocytes [#/volume] in Peritoneal fluid

551

1.49

3.02

2.3

1.9

e6/l

4576.3

12993.5

1.17

287

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

546

6309

0.86

3.00

1.5

—

(3005033) Fetal Nuchal fold Thickness US

398

4716

0.84

2.99

1.5

1.4

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

1795

16565

1.09

2.99

2.1

2.0

—

(3019832) Treponema pallidum Ab [Presence] in Serum

2505

23426

1.08

2.98

1.7

—

(3050794) Legionella sp Ab [Presence] in Serum

154

1.95

2.97

1.1

—

(3033923) Metanephrine [Moles/time] in 24 hour Urine

378

1.59

2.96

1.2

1.1

umol/24h

0.8

0.13

182

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

318

2615

1.22

2.96

1.9

1.8

titre

6466.7

2906.9

0.71

116

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

507

4347

1.17

2.95

2.5

2.4

ug/min

96.6

116.1

0.45

286

2652

(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid

530

1.49

2.94

1.1

—

(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid

212

1.79

2.93

1.1

—

(3032492) JC virus DNA [#/volume] (viral load) in Cerebral spinal fluid by NAA with probe detection

3.14

2.92

1.1

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

400

4725

0.84

2.91

1.5

1.4

—

(40760435) Tropomyosin IgE Ab [Units/volume] in Serum

235

1.74

2.89

1.1

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

204

1601

1.27

2.89

1.1

—

(3037556) Urate [Mass/volume] in Serum or Plasma

503

1.49

2.82

1.4

—

(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma

395

3334

1.19

2.80

1.4

1.5

nmol/l

0.3

0.4

1.00

306

2620

(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid

107

769

1.39

2.79

1.1

ng/l

188.6

512.6

0.98

175

(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

103

2.13

2.79

3.9

4.6

—

(3018688) Ampicillin IgE Ab [Units/volume] in Serum

2.64

2.78

1.0

—

(3006567) Chloride [Moles/time] in 24 hour Urine

3.22

2.76

1.7

1.1

—

(3042517) Benzodiazepines panel - Urine

307

1.63

2.76

2.0

2.8

—

(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection

2.20

2.72

2.1

1.7

—

(3000919) Neutrophils/100 leukocytes in Pleural fluid

435

1.52

2.70

1.2

1.4

31.1

20.8

1.79

396

(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma

130

970

1.34

2.69

2.2

u/l

200.3

200.5

0.01

130

962

(40768795) Lymph node Pathology biopsy report

224

1801

1.24

2.63

1.3

1.2

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

205

1.75

2.63

1.3

u/l

35.1

239.4

0.80

154

(3023430) Cat dander IgE Ab [Units/volume] in Serum

361

3045

1.19

2.61

1.1

u/ml

6.6

5.6

0.37

160

1336

(3025315) Body weight

162

1.85

2.59

6.5

4.0

—

(3042847) Granulocytes/100 leukocytes in Cerebral spinal fluid

134

1.94

2.58

1.1

1.2

4.2

19.9

—

(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen

424

1.51

2.58

1.1

1.2

—

(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen

424

1.51

2.58

1.1

1.2

—

(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen

424

1.51

2.58

1.1

1.2

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

497

1.47

2.58

1.1

—

(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum

3.60

2.56

2.0

—

(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum

3.60

2.56

1.0

—

(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum

3.60

2.56

2.0

—

(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination

3.60

2.56

1.0

—

(3033093) Yersinia sp IgM Ab [Titer] in Serum

3.60

2.56

2.0

—

(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination

3.60

2.56

1.0

—

(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection

108

2.04

2.50

4.0

4.7

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

108

2.04

2.50

1.4

1.5

—

(3013166) Neutrophils/100 leukocytes in Synovial fluid

542

1.44

2.49

1.5

1.4

48.6

55.3

0.84

461

(3035457) Cefaclor IgE Ab [Units/volume] in Serum

165

1.82

2.47

1.0

—

(3001893) Eosinophils/100 leukocytes in Pleural fluid

494

1.46

2.46

1.2

1.4

2.3

3.1

0.39

423

(3005532) Lymphocytes/100 leukocytes in Pleural fluid

585

1.42

2.46

1.3

1.4

52.1

64.1

2.45

490

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

686

1.38

2.45

1.4

pmol/l

14.5

15.0

0.48

570

(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid

256

1.64

2.42

1.1

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

744

6656

1.12

2.38

1.5

—

(3009466) Valproate [Moles/volume] in Serum or Plasma

353

2999

1.18

2.38

5.2

umol/l

359.5

370.2

0.71

307

2619

(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum

186

1486

1.25

2.35

1.1

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

105

2.00

2.29

3.0

1.4

—

(3050129) First trimester maternal screen panel - Serum or Plasma

680

7588

0.89

2.29

1.5

1.4

—

(3033799) Differential panel - Peritoneal fluid

553

1.41

2.27

2.3

1.9

—

(3036180) Methadone [Presence] in Urine

2.55

2.26

2.1

2.3

—

(3036005) Urine sediment comments by Light microscopy Narrative

3.88

2.24

1.0

1.2

—

(3032743) Legionella sp IgG Ab [Presence] in Serum

120

1.92

2.24

1.0

1.1

—

(3028707) Methadone [Presence] in Urine by Screen method

511

4489

1.14

2.23

2.5

2.9

—

(3023410) Appearance of Cerebral spinal fluid

250

2075

1.21

2.22

1.6

1.8

—

(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid

263

1.60

2.21

1.1

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

114

1.93

2.19

1.5

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

668

1.36

2.17

1.1

1.2

—

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

241

2886

0.83

2.15

1.4

1.3

mmol/l

7.2

7.1

0.12

175

2087

(3011288) Drugs identified in Urine by Screen method

785

7090

1.11

2.15

2.8

3.0

—

(3014133) Dog dander IgE Ab [Units/volume] in Serum

379

3270

1.16

2.14

1.1

u/ml

4.6

4.9

0.14

156

1374

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

2341

22112

1.06

2.13

4.4

4.2

32.1

0.04

1738

15351

(3025886) Oxalate [Mass/time] in 24 hour Urine

2.36

2.11

1.3

1.2

—

(3004446) Plasmodium sp identified in Blood by Light microscopy

220

1.64

2.10

2.6

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

232

2778

0.83

2.08

1.2

—

(3028917) Waxy casts [#/area] in Urine by Computer assisted method

4.99

2.07

1.0

1.1

—

(3030940) RBC casts [#/area] in Urine by Computer assisted method

4.99

2.07

1.0

1.1

—

(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma

131

1.83

2.06

1.0

1.1

u/l

19.2

8.6

0.47

131

(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk

683

1.35

2.06

1.0

—

(21494567) Legionella sp IgM Ab [Presence] in Serum

124

1.85

2.05

1.0

1.1

—

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

5680

54930

1.04

2.05

4.8

4.6

ug/l

2.5

3.1

1.57

5093

49469

(3034459) Mononuclear cells/100 leukocytes in Pleural fluid

184

1.68

2.02

1.3

1.4

73.1

69.9

0.21

156

(1002224) Polysomnography panel

935

8549

1.10

2.02

1.1

—

(43055442) Apixaban [Mass/volume] in Serum or Plasma

223

1.61

2.00

1.9

1.5

ug/l

106.5

115.1

0.22

184

(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)

408

1.45

2.00

1.3

—

(3041918) Cholesterol [Moles/volume] in Pleural fluid

303

1.52

1.98

1.2

mmol/l

1.8

1.7

0.13

187

(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method

133

1.80

1.98

2.5

5.4

—

(3021691) Plasmodium malariae Ab [Titer] in Serum

3.33

1.96

2.3

2.4

—

(3015350) Toxocara sp Ab [Presence] in Serum

3.33

1.96

1.0

—

(3022192) Triglyceride [Mass/volume] in Serum or Plasma

716

1.33

1.94

2.5

2.3

—

(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood

469

1.41

1.94

11.5

7.5

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

354

1.47

1.92

2.1

2.3

mmol/l

7.9

7.6

0.14

214

(3012984) Norclozapine [Mass/volume] in Serum or Plasma

241

0.46

1.91

10.2

7.6

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

105

805

1.30

1.91

1.8

1.9

—

(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection

719

1.32

1.90

1.1

—

(3046861) Legionella sp Ag [Presence] in Urine

2.00

1.89

1.2

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

135

1071

1.26

1.88

1.6

—

(3015183) Erythrocyte sedimentation rate

136

1080

1.26

1.88

1.2

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

710

0.69

1.87

3.6

3.1

—

(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen

709

0.69

1.86

7.1

6.3

—

(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing

304

0.53

1.85

1.0

1.2

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

382

1.44

1.85

1.1

—

(3002814) Trichinella spiralis Ab [Titer] in Serum

3.53

1.83

1.0

—

(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method

182

1.65

1.83

1.1

—

(3044007) Cell count panel - Peritoneal fluid

492

1.38

1.82

2.4

1.9

—

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

155

1256

1.23

1.81

1.4

1.3

umol/l

3.9

5.2

5.55

143

1155

(3010937) Rubella virus Ab [Presence] in Serum

131

1.75

1.76

1.0

1.1

—

(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid

141

1135

1.24

1.76

1.1

u/l

1.1

1.0

0.27

497

(3008116) Ketones [Moles/volume] in Urine by Test strip

412

1.41

1.74

1.8

1.4

—

(4094501)

543

4874

1.12

1.74

1.1

—

(3001686) Cold agglutinin [Titer] in Serum or Plasma

330

1.45

1.72

1.3

titre

52.0

154.4

—

(3033086) Enterovirus NOS Ab [Titer] in Serum

2.13

1.70

1.1

1.0

—

(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)

115

908

1.27

1.70

1.5

1.6

nmol/l

6.2

6.0

0.02

755

(3005011) Chlamydia sp Ab [Titer] in Serum

298

1.48

1.70

1.8

1.5

—

(3009677) Dengue virus Ab [Presence] in Serum

1.95

1.68

1.1

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

887

8179

1.09

1.64

2.0

2.2

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

2.03

1.63

1.2

1.3

nmol/l

376.9

578.3

0.86

(3020951) Lymphocytes/100 leukocytes in Cerebral spinal fluid

252

1.51

1.63

1.1

1.3

65.5

55.4

0.51

127

(3002067) Lambda light chains [Mass/time] in 24 hour Urine

244

1.52

1.63

2.8

2.9

—

(40757373) Influenza virus identified in Isolate

384

1.41

1.63

1.4

1.6

—

(3000034) Microalbumin [Mass/volume] in Urine

197

1657

1.19

1.61

3.4

3.0

mg/l

48.4

52.1

0.08

148

1200

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

337

2955

1.14

1.61

1.3

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

119

952

1.25

1.60

6.3

6.2

u/ml

483.5

3764.6

0.52

200

(3041008) Bicarbonate [Moles/volume] standard in Arterial cord blood

319

1.44

1.60

1.2

1.1

mmol/l

20.6

20.2

0.27

283

(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum

301

2623

1.15

1.58

1.1

u/ml

0.4

0.5

0.16

624

(3039443) Prostate specific Ag panel - Serum or Plasma

302

3448

0.87

1.58

1.5

1.6

—

(3004437) Lymphocytes/100 leukocytes in Peritoneal fluid

159

1.63

1.57

2.2

2.1

51.7

63.4

0.80

(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method

702

7645

0.91

1.57

1.6

1.7

mg/l

3.8

3.5

0.41

516

5291

(3011335) Digoxin [Mass/volume] in Serum or Plasma

129

1.70

1.55

3.3

2.1

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

19268

190947

1.04

1.53

4.4

4.1

mmol/l

4.6

4.7

33.45

18079

178308

(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

216

1.53

1.52

1.1

—

(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma

332

1.41

1.50

1.3

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

1.94

1.48

1.1

1.2

nmol/l

204.3

269.2

1.22

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

139

1144

1.21

1.46

1.4

1.3

—

(3014891) Appearance of Pleural fluid

203

1.53

1.44

1.7

1.6

—

(3044416) Complement C4 [Mass/volume] in Pleural fluid

1.87

1.43

1.0

1.1

g/l

0.1

—

(3032185) JC virus DNA [#/volume] (viral load) in Serum or Plasma by NAA with probe detection

1.92

1.43

7.3

6.5

—

(3051593) INR in Capillary blood by Coagulation assay

770

1.26

1.43

7.4

10.4

—

(3007700) Barley IgE Ab [Units/volume] in Serum

1.79

1.42

1.1

u/ml

61.5

0.5

0.48

(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay

245

1.47

1.40

1.2

—

(3028029) Mesothelial cells/100 leukocytes in Pleural fluid

237

1.48

1.40

1.2

1.4

10.1

11.4

0.14

123

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

255

1.45

1.36

9.5

11.5

umol/l

0.3

0.4

0.20

231

(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot

2.61

1.36

2.2

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

813

0.76

1.36

1.0

—

(3028717) Thiamine [Mass/volume] in Blood

198

1.51

1.36

1.2

—

(3038071) Oxygen [Partial pressure] in Mixed venous blood

417

1.34

1.33

12.2

7.5

—

(40771922) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood

175

1.54

1.33

1.4

1.3

ml/s/173m2

1.5

1.7

0.17

121

(46234826) Other cells/100 leukocytes in Peritoneal fluid by Manual count

128

1.64

1.32

1.8

2.1

7.8

16.4

—

(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture

216

1.48

1.31

1.9

2.0

—

(3051101) Glucose [Moles/volume] in Cord blood

307

0.62

1.30

4.8

5.6

—

(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma

1.73

1.30

1.0

1.1

—

(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid

385

1.35

1.29

1.5

1.4

20.4

24.4

0.56

326

(3012989) Citrate [Moles/time] in 24 hour Urine

2.35

1.29

2.5

1.4

mmol/24h

1.4

2.2

—

(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid

145

1.58

1.28

1.0

—

(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture

177

1.52

1.27

2.0

2.2

—

(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis

114

1.67

1.27

1.1

1.2

—

(3046904) Somatotropin [Units/volume] in Serum or Plasma

2.28

1.26

2.3

mu/l

3.6

2.5

—

(3027300) Silver Birch IgE Ab [Units/volume] in Serum

695

1.25

1.1

1.0

u/ml

12.2

9.7

0.24

(40768806) Pleura Pathology biopsy report

196

1691

1.16

1.25

1.5

1.6

—

(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma

1074

11381

0.94

1.23

1.5

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

314

0.64

1.23

1.6

2.5

—

(40768800) Prostate Pathology biopsy report

282

3168

0.89

1.22

1.2

—

(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid

155

1.55

1.21

1.0

—

(40758292) HTLV I+II Ab panel - Serum

338

1.36

1.21

1.3

—

(44806071)

272

1.40

1.18

1.1

—

(3028300) Cannabinoids [Presence] in Urine

1126

10627

1.06

1.17

1.9

2.1

—

(723473) SARS-CoV-2 (COVID-19) IgA Ab [Presence] in Serum or Plasma by Immunoassay

125

1.60

1.16

1.2

1.1

—

(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain

327

2934

1.11

1.16

1.4

1.5

—

(3049242) von Willebrand panel - Platelet poor plasma

1.93

1.16

2.1

1.5

—

(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field

1.77

1.16

1.1

1.3

u/field

0.6

1.2

—

(3027008) Opiates [Presence] in Urine

1123

10603

1.06

1.16

1.9

2.1

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

102

1.66

1.15

22.3

8.0

—

(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid

127

1068

1.19

1.13

1.0

ng/l

822.2

734.4

1.30

731

(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

199

1.46

1.13

1.1

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

458

4189

1.09

1.12

1.8

1.7

—

(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay

127

1070

1.19

1.11

1.0

ng/l

32.8

41.8

2.63

732

(3015616) Isopropanol [Moles/volume] in Serum or Plasma

217

1.43

1.10

1.2

1.4

mmol/l

—

1.7

—

(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

441

1.29

1.09

1.1

—

(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay

226

1.41

1.08

1.2

1.1

—

(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal

133

1558

0.85

1.08

1.6

1.5

—

(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid

126

1065

1.18

1.07

1.0

ng/l

275.5

351.5

1.19

749

(3049506) Microalbumin [Mass/time] in Urine collected for unspecified duration

105

874

1.20

1.06

2.0

2.1

ug/min

61.4

122.6

0.78

203

(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid

244

1.39

1.06

1.1

—

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

844

7928

1.07

1.05

2.0

1.8

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

18456

183109

1.03

1.05

4.0

3.7

mmol/l

1.3

15.74

17143

169412

(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy

113

1.59

1.04

1.1

—

(3008994) Creatine kinase.BB [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.71

1.04

1.5

1.6

u/l

0.6

0.1

—

(3005082) Progesterone [Moles/volume] in Serum or Plasma

1162

0.83

1.03

1.4

nmol/l

32.2

31.5

0.07

1060

(40759632) Porphyrins [Mass/mass] in Stool

2.27

1.03

1.2

1.0

—

(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

263

1.37

1.02

1.1

1.0

—

(3018081) Beta-2-Microglobulin [Mass/volume] in Urine

1.88

1.00

2.4

1.3

mg/l

9.9

5.3

—

(3016879) Cocaine [Presence] in Urine

1038

9830

1.06

1.00

2.0

2.2

—

(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection

1.76

1.00

1.3

1.1

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

154

1770

0.87

1.00

1.6

mmol/l

7.5

7.7

0.57

1068

(3007542) Rye IgE Ab [Units/volume] in Serum

107

1.59

0.99

1.1

u/ml

81.4

0.2

0.48

(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma

459

0.74

0.98

1.4

1.2

—

(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis

1.83

0.98

2.6

1.3

—

(21494227) Amikacin free [Mass/volume] in Serum or Plasma

1.83

0.98

5.6

5.2

mg/l

12.3

6.5

—

(3016913) Creatine kinase.MM [Enzymatic activity/volume] in Serum or Plasma by Electrophoresis

1.71

0.98

1.1

u/l

206.1

556.5

1.14

(3042934) Triiodothyronine (T3) Ab [Presence] in Serum

2.17

0.98

1.2

1.0

—

(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection

1.80

0.98

4.5

3.1

—

(1617658) Protocol used for examination of sentinel lymph nodes

110

1295

0.85

0.97

1.0

—

(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid

249

1.36

0.96

1.1

—

(3009461) 5-Hydroxyindoleacetate [Moles/time] in 24 hour Urine

1.85

0.96

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

327

1.31

0.96

1.1

—

(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid

116

1.55

0.95

1.0

—

(3006598) pH of Arterial cord blood

241

1.37

0.95

1.1

1.0

—

(3004959) Base excess in Arterial cord blood by calculation

241

1.37

0.95

1.1

1.0

mmol/l

-1.7

-1.5

—

(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]

354

1.30

0.94

7.5

5.5

62.5

69.7

0.92

274

(3012320) Pathologist interpretation of Cerebral spinal fluid tests

381

1.29

0.93

1.3

—

(3000764) Benzodiazepines [Presence] in Urine

1108

10542

1.05

0.92

1.9

2.1

—

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

365

1.29

0.91

1.1

1.2

mg/l

126.4

36.6

0.31

268

(3018291) Platelet Ab [Presence] in Serum

2.14

0.91

1.3

1.0

—

(3034092) Cytoplasmic Ig cells/100 cells in Blood

269

1.34

0.91

8.8

8.1

—

(3027944) Amphetamines [Presence] in Urine

1097

10444

1.05

0.90

1.8

2.1

—

(3027318) Ethylene glycol [Moles/volume] in Serum or Plasma

1.74

0.89

1.0

1.2

mmol/l

—

(3042975) Streptococcus sp identified in Isolate by Organism specific culture

164

1445

1.13

0.86

1.3

1.2

—

(3020356) Listeria sp identified in Specimen by Organism specific culture

136

1.47

0.85

1.2

1.1

—

(3013762) Body weight Measured

1.66

0.84

1.0

1.2

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

1.93

0.84

1.2

1.1

nmol/24h

119.6

82.6

—

(40763480) Human metapneumovirus Ag [Presence] in Specimen

112

1.52

0.84

1.0

1.5

—

(3025549) Creatine [Moles/time] in 24 hour Urine

145

1.45

0.84

1.7

1.4

—

14.7

—

(3019779) Phenytoin [Moles/volume] in Serum or Plasma

230

1.35

0.83

5.2

3.4

umol/l

39.3

40.9

0.12

196

(3049233) Organic acids panel - Urine

1.75

0.83

1.1

1.2

—

(44786800) Granulocytes/100 leukocytes in Body fluid

205

1.36

0.82

1.3

28.4

23.4

0.29

163

(3032868) Hemoglobin electrophoresis panel in Blood

201

0.65

0.81

1.5

1.6

—

(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma

132

1155

1.14

0.79

6.4

6.7

—

(3034099) Cytomegalovirus Ab [Titer] in Cerebral spinal fluid

1.82

0.79

1.0

1.1

—

(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method

0.00

0.78

0.0

1.0

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

127

1447

0.88

0.78

10.7

13.7

nmol/l

732.5

824.1

1.70

120

1398

(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection

428

1.24

0.78

1.2

—

(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma

148

1307

1.13

0.77

11.3

11.9

mmol/l

0.6

0.03

138

1201

(3028531) Enolase.neuron specific [Mass/volume] in Serum or Plasma

235

2131

1.10

0.77

1.8

2.0

ug/l

19.4

23.3

0.97

230

2079

(40762887) Creatinine [Moles/volume] in Blood

1.76

0.76

1.2

—

(3012898) Urea [Moles/volume] in Urine

200

1.35

0.75

1.1

1.5

mmol/l

185.2

170.7

0.16

183

(3003843) Paprika IgE Ab [Units/volume] in Serum

1.70

0.75

1.0

u/ml

0.1

—

(3022670) pH of Venous cord blood

1.60

0.74

1.0

—

(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma

1.84

0.73

1.0

1.1

2.0

3.0

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

19070

189551

1.02

0.72

4.3

4.1

mmol/l

1.4

1.5

7.87

17807

176264

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

19501

193884

1.02

0.72

4.7

4.5

mmol/l

2.7

2.8

35.62

18175

179985

(4146454)

201

1817

1.11

0.72

2.8

2.7

—

(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid

1.92

0.70

1.2

1.0

—

(3044009) aPTT.lupus sensitive (LA screen)

194

1.34

0.70

1.0

1.2

—

(3046299) Protein.monoclonal [Mass/volume] in Serum or Plasma by Electrophoresis

126

1.43

0.69

4.2

5.3

—

(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen

1.50

0.69

1.0

1.4

—

(3000285) Sodium [Moles/volume] in Blood

221

1.31

0.69

1.2

1.1

—

(3019174) dRVVT (LA screen)

195

1.33

0.68

1.1

1.2

—

(3029612) Listeria sp Ab [Titer] in Serum

1.66

0.68

1.1

1.3

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

117

0.60

0.67

1.0

1.1

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

147

1313

1.12

0.67

1.7

2.0

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

136

1516

0.90

0.63

15.0

19.3

nmol/l

1369.8

2049.9

0.55

130

1454

(3022725) Serotonin [Moles/volume] in Serum

1.55

0.61

1.3

1.5

nmol/l

1021.6

991.2

0.03

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

206

1885

1.09

0.61

1.3

1.4

mmol/l

11.0

11.8

0.54

445

(3032352) Blasts [#/volume] in Cerebral spinal fluid

217

1.29

0.61

2.3

3.1

—

(3026470) Cobalt [Mass/volume] in Blood

111

984

1.13

0.60

2.1

2.0

ug/l

3.0

3.7

0.73

867

(40760512) CD34 cells/100 cells in Bone marrow

0.00

0.59

0.0

1.7

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

140

1260

1.11

0.58

1.2

1.3

g/l

1.3

1.5

—

(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay

140

1.36

0.57

1.2

1.1

—

(3004268) Protein electrophoresis panel - Cerebral spinal fluid

1.66

0.56

1.2

1.1

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

265

2843

0.93

0.56

3.4

3.6

u/ml

53.9

35.9

0.50

254

2741

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

2277

22224

1.03

0.56

1.7

—

(3029847) von Willebrand factor (vWf).collagen binding activity actual/normal in Platelet poor plasma by Immunoassay

1.62

0.55

3.0

1.2

86.2

64.7

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

145

1318

1.10

0.52

1.2

1.5

—

(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine

134

1.34

0.52

1.3

2.5

—

(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum

178

1.29

0.52

1.0

1.1

—

(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method

1.43

0.52

1.0

1.1

—

(3034037) Hematocrit [Volume Fraction] of Mixed venous blood

296

1.21

0.50

7.9

7.4

—

(40760410) HLA-B [Type] by High resolution

1.46

0.50

1.0

—

(46236302) HLA-C [Type] by High resolution typing

1.46

0.50

1.0

—

(40760409) HLA-A [Type] by High resolution

1.46

0.50

1.0

—

(40763590) HLA-DQ beta [Type]

1.46

0.50

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

105

1164

0.90

0.48

1.4

mmol/l

5.5

5.6

0.64

1103

(43055458) Rivaroxaban [Mass/volume] in Serum or Plasma

145

1.31

0.48

1.2

ug/l

63.7

111.1

1.96

(40762814) Titanium [Mass/volume] in Blood

272

1.21

0.46

2.3

ug/l

3.4

3.9

0.52

(3024316) Viscosity of Plasma

1.41

0.46

1.5

mpas

1.6

—

(40765091) Chromosome analysis panel - Chorionic villus sample by G-banded

0.62

0.45

1.0

—

(3013862) HLA-DP [Type]

1.43

0.45

1.0

—

(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method

151

0.73

0.43

1.0

—

(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose

240

0.79

0.42

1.5

1.2

—

(3014444) EGFR gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal

140

1.28

0.41

1.1

—

(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma

289

3046

0.95

0.40

1.3

ug/l

3.3

4.0

0.54

259

2745

(40771901) t(9;22)(q34.1;q11)(ABL1,BCR) b2a2+b3a2 fusion transcript/control transcript (International Scale) [# Ratio] in Blood or Tissue by Molecular genetics method

1.39

0.40

9.7

—

(21491979) Prolactin monomeric [Units/volume] in Serum or Plasma

805

1.10

0.39

1.3

1.4

mu/l

456.6

581.0

0.66

767

(46235168) Fasting glucose [Moles/volume] in Blood

259

0.81

0.39

1.2

2.2

mmol/l

6.0

7.8

—

(3016184) Myelin associated glycoprotein Ab [Units/volume] in Serum

1.34

0.39

1.3

1.2

—

10925.0

—

(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma

133

1228

1.08

0.38

1.6

2.0

—

(3025577) Chromium [Mass/volume] in Blood

105

961

1.09

0.37

2.1

2.0

ug/l

2.0

2.4

0.83

799

(3032641) Amino acids panel - Urine

1.35

0.37

1.6

1.2

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

179

1.23

0.36

1.2

1.1

umol/24h

1.6

1.8

0.34

179

(3022689) Creatine [Moles/volume] in Urine

553

1.12

0.36

1.7

1.5

—

(40758358) Immune stain study

0.66

0.35

1.0

—

(3040491) Angiotensin converting enzyme [Enzymatic activity/volume] in Pleural fluid

189

1.22

0.35

1.1

u/l

28.0

20.2

0.41

122

(3031309) Prolactin monomeric/Prolactin.total in Serum or Plasma

822

1.09

0.34

1.3

1.4

72.8

72.7

0.01

784

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

442

4250

1.04

0.34

1.5

—

(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid

518

1.12

0.34

1.0

1.1

—

(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay

208

0.82

0.31

1.1

—

(4281824)

187

1973

0.95

0.31

1.2

1.1

—

(3040562) Leukocytes [#/volume] in Peritoneal dialysis fluid by Manual count

1.32

0.30

6.9

8.2

—

(3004347) Hepatitis D virus Ab [Presence] in Serum

1.32

0.30

1.0

—

(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method

156

1.22

0.30

1.0

1.1

—

(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma

372

1.13

0.29

1.6

1.8

ug/l

1.9

3.0

0.55

212

(3031659) Enterovirus NOS Ab [Titer] in Cerebral spinal fluid

1.23

0.29

1.3

1.1

—

(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid

439

1.11

0.28

1.3

ug/l

267.6

324.8

0.11

237

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

3111

31423

0.99

0.28

2.8

2.9

ug/l

0.7

0.8

2.09

2015

19860

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

121

1.24

0.28

1.1

1.0

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

423

4086

1.03

0.28

4.5

3.3

mg/l

24.4

27.6

1.23

268

2591

(43534046) Estradiol (E2) [Moles/volume] in Serum or Plasma by High sensitivity method

421

1.12

0.28

1.5

1.7

nmol/l

0.2

0.14

306

(4212803)

158

1.20

0.27

1.1

—

(3016273) Islet cell 512 Ab [Units/volume] in Serum

197

1.17

0.25

1.0

—

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

101

946

1.07

0.24

1.3

—

(40768793) Breast Pathology biopsy report

407

3945

1.03

0.24

1.3

—

(3027540) Rickettsia typhi Ab [Titer] in Serum

1.25

0.22

1.4

1.1

—

(40763641) Cell count and Differential panel - Peritoneal dialysis fluid

1.22

0.22

2.2

4.5

—

(3029396) Erythrocyte agglutination [Presence] in Blood

631

1.08

0.22

3.0

2.9

—

(3018738) Hemoglobin F/Hemoglobin.total in Blood

191

1.15

0.21

2.8

3.6

14.2

8.6

—

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

122

1283

0.95

0.21

1.9

1.8

—

(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture

491

0.92

0.21

1.7

1.9

—

(3018980) carBAMazepine [Moles/volume] in Serum or Plasma

677

0.93

0.21

2.3

2.9

umol/l

26.2

28.9

1.71

510

(3001556) Androgen free Index in Serum or Plasma

258

1.12

0.20

1.3

—

(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination

1.22

0.20

1.0

1.1

—

(40758047) Lysozyme [Mass/volume] in Pleural fluid

155

1.16

0.19

1.1

1.2

mg/l

8.6

9.4

0.09

137

(3001019) Free T4 and TSH panel - Serum or Plasma

1130

11124

1.02

0.19

1.7

1.6

—

(4198724)

127

1211

1.05

0.19

2.2

2.5

—

(3003985) Beta hydroxybutyrate [Moles/volume] in Serum or Plasma

318

1.10

0.18

3.3

2.4

mmol/l

0.9

1.5

2.46

232

(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay

280

1.11

0.18

1.0

1.1

—

(3042552) Rheumatoid factor [Units/volume] in Pleural fluid

147

1.16

0.17

1.1

iu/ml

14.8

17.0

—

(43055514) Macroprolactin [Presence] in Serum or Plasma

619

1.07

0.17

1.3

1.4

—

(4038314)

205

0.88

0.17

1.2

—

(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma

361

0.91

0.17

1.1

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

262

1.11

0.17

1.0

—

(3001729) Color of Synovial fluid

141

0.85

0.16

1.2

1.6

—

(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum

1.15

0.15

1.1

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

226

1.10

0.14

1.8

2.5

u/field

0.4

0.6

0.24

226

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

501

5093

0.98

0.14

1.8

—

(3007463) Buprenorphine [Presence] in Urine

118

0.85

0.14

4.8

7.1

—

(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture

110

0.82

0.13

3.7

3.2

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

926

0.96

0.12

2.7

2.5

umol/l

54.9

53.8

0.16

796

(44806420)

456

0.94

0.12

2.4

—

(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection

105

1.14

0.11

1.2

1.3

—

(40766799) MGMT gene methylation score in Tissue by Molecular genetics method

125

0.88

0.10

1.0

—

(4133840)

585

0.96

0.10

1.3

1.2

—

(3003577) Lead [Moles/volume] in Blood

176

0.91

0.09

1.6

1.5

umol/l

0.3

0.2

—

(3041806) Other cells [#/volume] in Blood by Manual count

104

1012

1.03

0.08

1.6

1.4

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

555

5496

1.01

0.06

1.5

—

(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay

295

1.05

0.06

1.0

1.1

—

(3045781) Inhibin B [Mass/volume] in Serum or Plasma

545

0.97

0.05

2.2

2.5

ng/l

121.1

119.8

0.02

331

(3014064) Pregnancy associated plasma protein A [Multiple of the median] in Serum or Plasma

169

1.06

0.04

1.1

1.0

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

4372

43613

1.00

0.03

4.1

4.0

21.2

21.9

2.08

1991

19837

(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain

300

1.03

0.03

1.1

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

178

1766

1.01

0.02

1.4

1.3

pmol/l

72.3

88.5

0.37

524

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

127

1.02

0.00

1.4

1.3

—

(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid

137

1.02

0.00

1.1

1.4

43.9

32.2

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

819

1.00

0.00

1.1

—

(3017509) Phencyclidine [Presence] in Urine

290

1.00

0.00

2.7

2.0

—

(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method

100

1.00

0.00

1.0

—

(3014257) Rhodotorula spp IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3026868) Penicillium brevicompactum IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(43055187) t(12;21)(p13;q22.3)(ETV6,RUNX1) fusion transcript/control transcript [# Ratio] in Bone marrow by Molecular genetics method

0.00

0.0

4.0

—

(3029889) Paecilomyces variottii IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3020071) Venlafaxine [Mass/volume] in Serum or Plasma

0.00

0.0

1.0

—

(3006498) Trichoderma viride IgE Ab [Units/volume] in Serum

0.00

0.0

1.0

—

(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma

0.98

0.00

1.7

2.2

—

(3005117) Influenza virus A Ab [Titer] in Serum

0.00

0.0

1.0

—

(3006392) Corynebacterium diphtheriae [Presence] in Specimen by Organism specific culture

0.00

0.0

1.0

—

(3014591) Smooth Alder IgE Ab [Units/volume] in Serum

0.89

0.00

1.0

—

(3034614) HLA Ag [Interpretation]

1.00

0.00

1.4

1.2

—

(3019529) Immunofixation for Cerebral spinal fluid

0.00

0.0

1.1

—

Mortality – FinRegistry

↥

Association

Association between endpoint K11_ENERCOLNONINF and mortality.

Females

Parameter	HR [95% CI]	p-value
K11_ENERCOLNONINF	1.701 [1.55, 1.86]	< 0.001
Birth year	0.99 [0.98, 1.0]	0.018

During the follow-up period (1.1.1998 — 31.12.2019), 11743 out of 70595 females with K11_ENERCOLNONINF died.

Males

Parameter	HR [95% CI]	p-value
K11_ENERCOLNONINF	1.654 [1.5, 1.82]	< 0.001
Birth year	0.986 [0.98, 0.99]	0.002

During the follow-up period (1.1.1998 — 31.12.2019), 9704 out of 66983 males with K11_ENERCOLNONINF died.

Mortality risk

Mortality risk for people of age

years, who have K11_ENERCOLNONINF.

N-year risk	Females	Males
1	0.156%	0.326%
5	0.8%	1.753%
10	2.043%	4.466%
15	3.902%	8.586%
20	6.929%	14.303%

Relationships between endpoints

↥

Index endpoint: K11_ENERCOLNONINF – Noninfective enteritis and colitis

GWS hits: 53

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Noninfective enteritis and colitis

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints